1
|
Gewirtz-Meydan A, Koós M, Nagy L, Kraus SW, Demetrovics Z, Potenza MN, Ballester-Arnal R, Batthyány D, Bergeron S, Billieux J, Burkauskas J, Cárdenas-López G, Carvalho J, Castro-Calvo J, Chen L, Ciocca G, Corazza O, Csako R, Fernandez DP, Fujiwara H, Fernandez EF, Fuss J, Gabrhelík R, Gjoneska B, Gola M, Grubbs JB, Hashim HT, Islam MS, Ismail M, Jiménez-Martínez MC, Jurin T, Kalina O, Klein V, Költő A, Lee SK, Lewczuk K, Lin CY, Lochner C, López-Alvarado S, Lukavská K, Mayta-Tristán P, Miller DJ, Orosová O, Orosz G, Ponce FP, Quintana GR, Quintero Garzola GC, Ramos-Diaz J, Rigaud K, Rousseau A, De Tubino Scanavino M, Schulmeyer MK, Sharan P, Shibata M, Shoib S, Sigre-Leirós V, Sniewski L, Spasovski O, Steibliene V, Stein DJ, Strong C, Ünsal BC, Vaillancourt-Morel MP, Van Hout MC, Bőthe B. Global cross-cultural validation of a brief measure for identifying potential suicide risk in 42 countries. Public Health 2024; 229:13-23. [PMID: 38382177 DOI: 10.1016/j.puhe.2023.12.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Revised: 12/11/2023] [Accepted: 12/29/2023] [Indexed: 02/23/2024]
Abstract
OBJECTIVES This study aimed to examine the psychometric properties of the P4 suicide screener in a multinational sample. The primary goal was to evaluate the reliability and validity of the scale and investigate its convergent validity by analyzing its correlation with depression, anxiety, and substance use. STUDY DESIGN The study design is a cross-sectional self-report study conducted across 42 countries. METHODS A cross-sectional, self-report study was conducted in 42 countries, with a total of 82,243 participants included in the final data set. RESULTS The study provides an overview of suicide ideation rates across 42 countries and confirms the structural validity of the P4 screener. The findings indicated that sexual and gender minority individuals exhibited higher rates of suicidal ideation. The P4 screener showed adequate reliability, convergence, and discriminant validity, and a cutoff score of 1 is recommended to identify individuals at risk of suicidal behavior. CONCLUSIONS The study supports the reliability and validity of the P4 suicide screener across 42 diverse countries, highlighting the importance of using a cross-cultural suicide risk assessment to standardize the identification of high-risk individuals and tailoring culturally sensitive suicide prevention strategies.
Collapse
Affiliation(s)
- A Gewirtz-Meydan
- School of Social Work, Faculty of Social Welfare and Health Sciences, University of Haifa, Israel. Agewirtz-@univ.haifa.ac.il
| | - M Koós
- Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Institute of Forensic Psychiatry and Sex Research, University of Duisburg-Essen, Essen, Germany
| | - L Nagy
- Doctoral School of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary
| | - S W Kraus
- Department of Psychology, University of Nevada, Las Vegas, Las Vegas, NV, USA
| | - Z Demetrovics
- Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, Gibraltar
| | - M N Potenza
- Yale University School of Medicine, New Haven, CT, USA; Connecticut Council on Problem Gambling, Wethersfield, CT, USA
| | - R Ballester-Arnal
- Departmento de Psicología Básica, Clínica y Psicobiología, University Jaume I of Castellón, Spain
| | - D Batthyány
- Institute for Behavioural Addictions, Sigmund Freud University Vienna, Austria
| | - S Bergeron
- Département de Psychologie, Université de Montréal, Montréal, Canada
| | - J Billieux
- Institute of Psychology, University of Lausanne, Lausanne, Switzerland; Center for Excessive Gambling, Addiction Medicine, Lausanne University Hospitals (CHUV), Lausanne, Switzerland
| | - J Burkauskas
- Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Lithuania
| | - G Cárdenas-López
- Virtual Teaching and Cyberpsychology Laboratory, School of Psychology, National Autonomous University of Mexico, Mexico
| | - J Carvalho
- William James Center for Research, Departamento de Educação e Psicologia, Universidade de Aveiro, Aveiro, Portugal
| | - J Castro-Calvo
- Department of Personality, Assessment, and Psychological Treatments, University of Valencia, Spain
| | - L Chen
- Department of Psychology, College of Humanity and Social Science, Fuzhou University, China
| | - G Ciocca
- Section of Sexual Psychopathology, Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Rome, Italy
| | - O Corazza
- Department of Clinical, Pharmaceutical and Biological Sciences, University of Hertfordshire, UK; Department of Psychology and Cognitive Science, University of Trento, Italy
| | - R Csako
- Department of Psychology and Neuroscience, Auckland University of Technology, Auckland, New Zealand
| | | | - H Fujiwara
- Department of Neuropsychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Decentralized Big Data Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan
| | | | - J Fuss
- Institute of Forensic Psychiatry and Sex Research, Center for Translational Neuro- and Behavioral Sciences, University of Duisburg-Essen, Essen, Germany
| | - R Gabrhelík
- Charles University, First Faculty of Medicine, Department of Addictology, Prague, Czech Republic; General University Hospital in Prague, Department of Addictology, Czech Republic
| | - B Gjoneska
- Macedonian Academy of Sciences and Arts, Macedonia
| | - M Gola
- Institute of Psychlogy, Polish Academy of Sciences, Poland; Institute for Neural Computations, University of California San Diego, USA
| | - J B Grubbs
- University of New Mexico, Albuquerque, USA; Center for Alcohol, Substance Use, And Addiction (CASAA), University of New Mexico, Albuquerque, USA
| | - H T Hashim
- University of Baghdad, College of Medicine, Iraq
| | - M S Islam
- Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh; Centre for Advanced Research Excellence in Public Health, Savar, Dhaka 1342, Bangladesh
| | - M Ismail
- University of Baghdad, College of Medicine, Iraq
| | - M C Jiménez-Martínez
- Universidad Pedagógca y Tecnológica de Colombia, Colombia; Grupo de Investigación Biomédica y de Patología, Colombia
| | - T Jurin
- Department of Psychology, Humanities and Social Sciences, University of Zagreb, Croatia
| | - O Kalina
- Department of Educational Psychology and Psychology of Health, Pavol Jozef Safarik University in Kosice, Slovakia
| | - V Klein
- School of Psychology, University of Southampton, UK
| | - A Költő
- Health Promotion Research Centre, University of Galway, Ireland, UK
| | - S-K Lee
- Department of Psychiatry, Hallym University Chuncheon Sacred Heart Hospital, South Korea; Chuncheon Addiction Management Center, South Korea
| | - K Lewczuk
- Institute of Psychology, Cardinal Stefan Wyszynski University, Warsaw, Poland
| | - C-Y Lin
- Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
| | - C Lochner
- SAMRC Unit on Risk & Resilience in Mental Disorders, Stellenbosch University, South Africa
| | | | - K Lukavská
- Charles University, First Faculty of Medicine, Department of Addictology, Prague, Czech Republic; Charles University, Faculty of Education, Department of Psychology, Prague, Czech Republic
| | - P Mayta-Tristán
- Facultad de Medicina, Universidad Científica del Sur, Lima, Peru
| | - D J Miller
- College of Healthcare Sciences, James Cook University, Australia
| | - O Orosová
- Pavol Jozef Safarik University in Kosice, Department of Educational Psychology and Psychology of Health, Slovakia
| | | | - F P Ponce
- Facultad de Psicología, Universidad de Talca, Chile
| | - G R Quintana
- Departamento de Psicología y Filosofía, Facultad de Ciencias Sociales, Universidad de Tarapacá, Arica, Arica y Parinacota, Chile
| | - G C Quintero Garzola
- Florida State University, Panama; Sistema Nacional de Investigación (SNI), SENACYT, Panama
| | - J Ramos-Diaz
- Facultad de Ciencias de la Salud, Universidad Privada del Norte, Lima, Perú
| | | | - A Rousseau
- Leuven School for Mass Communication, KU Leuven, Leuven, Belgium
| | - M De Tubino Scanavino
- Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, Brazil; Experimental Pathophisiology Post Graduation Program, Faculdade de Medicina, Universidade de São Paulo, Brazil
| | | | - P Sharan
- Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, 110029, India
| | - M Shibata
- Department of Neuropsychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - S Shoib
- Department of Psychology, Shardha University, India; Department of Health Kashmir, India
| | - V Sigre-Leirós
- Institute of Psychology, University of Lausanne, Lausanne, Switzerland; Institute of Legal Psychiatry, Lausanne University Hospitals (CHUV), Lausanne, Switzerland
| | - L Sniewski
- Auckland University of Technology, New Zealand
| | - O Spasovski
- Faculty of Philosophy, Ss. Cyril and Methodius University in Skopje, Macedonia; Faculty of Philosophy, University of Ss. Cyril and Methodius in Trnava, Slovakia
| | - V Steibliene
- Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Lithuania
| | - D J Stein
- SAMRC Unit on Risk & Resilience in Mental Disorders, Dept of Psychiatry & Neuroscience Institute, University of Cape Town, South Africa
| | - C Strong
- Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan
| | - B C Ünsal
- Doctoral School of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary
| | - M-P Vaillancourt-Morel
- Département de Psychologie, Université du Québec à Trois-Rivières, Trois-Rivières, Canada
| | - M C Van Hout
- Public Health Institute, Faculty of Health, Liverpool John Moores University, UK
| | - B Bőthe
- Département de Psychologie, Université de Montréal, Montréal, Canada; Département de Psychologie, Université du Québec à Trois-Rivières, Trois-Rivières, Canada
| |
Collapse
|
2
|
Abratenko P, Alterkait O, Andrade Aldana D, Arellano L, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barr G, Barrow D, Barrow J, Basque V, Benevides Rodrigues O, Berkman S, Bhanderi A, Bhat A, Bhattacharya M, Bishai M, Blake A, Bogart B, Bolton T, Book JY, Brunetti MB, Camilleri L, Cao Y, Caratelli D, Cavanna F, Cerati G, Chappell A, Chen Y, Conrad JM, Convery M, Cooper-Troendle L, Crespo-Anadón JI, Cross R, Del Tutto M, Dennis SR, Detje P, Devitt A, Diurba R, Djurcic Z, Dorrill R, Duffy K, Dytman S, Eberly B, Englezos P, Ereditato A, Evans JJ, Fine R, Finnerud OG, Foreman W, Fleming BT, Franco D, Furmanski AP, Gao F, Garcia-Gamez D, Gardiner S, Ge G, Gollapinni S, Gramellini E, Green P, Greenlee H, Gu L, Gu W, Guenette R, Guzowski P, Hagaman L, Hen O, Hilgenberg C, Horton-Smith GA, Imani Z, Irwin B, Ismail M, James C, Ji X, Jo JH, Johnson RA, Jwa YJ, Kalra D, Kamp N, Karagiorgi G, Ketchum W, Kirby M, Kobilarcik T, Kreslo I, Leibovitch MB, Lepetic I, Li JY, Li K, Li Y, Lin K, Littlejohn BR, Liu H, Louis WC, Luo X, Mariani C, Marsden D, Marshall J, Martinez N, Martinez Caicedo DA, Martynenko S, Mastbaum A, Mawby I, McConkey N, Meddage V, Micallef J, Miller K, Mogan A, Mohayai T, Mooney M, Moor AF, Moore CD, Mora Lepin L, Moudgalya MM, Mulleriababu S, Naples D, Navrer-Agasson A, Nayak N, Nebot-Guinot M, Nowak J, Oza N, Palamara O, Pallat N, Paolone V, Papadopoulou A, Papavassiliou V, Parkinson HB, Pate SF, Patel N, Pavlovic Z, Piasetzky E, Pophale I, Qian X, Raaf JL, Radeka V, Rafique A, Reggiani-Guzzo M, Ren L, Rochester L, Rodriguez Rondon J, Rosenberg M, Ross-Lonergan M, Rudolf von Rohr C, Safa I, Scanavini G, Schmitz DW, Schukraft A, Seligman W, Shaevitz MH, Sharankova R, Shi J, Snider EL, Soderberg M, Söldner-Rembold S, Spitz J, Stancari M, St John J, Strauss T, Szelc AM, Tang W, Taniuchi N, Terao K, Thorpe C, Torbunov D, Totani D, Toups M, Tsai YT, Tyler J, Uchida MA, Usher T, Viren B, Weber M, Wei H, White AJ, Wolbers S, Wongjirad T, Wospakrik M, Wresilo K, Wu W, Yandel E, Yang T, Yates LE, Yu HW, Zeller GP, Zennamo J, Zhang C. Search for Heavy Neutral Leptons in Electron-Positron and Neutral-Pion Final States with the MicroBooNE Detector. Phys Rev Lett 2024; 132:041801. [PMID: 38335355 DOI: 10.1103/physrevlett.132.041801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 11/30/2023] [Indexed: 02/12/2024]
Abstract
We present the first search for heavy neutral leptons (HNLs) decaying into νe^{+}e^{-} or νπ^{0} final states in a liquid-argon time projection chamber using data collected with the MicroBooNE detector. The data were recorded synchronously with the NuMI neutrino beam from Fermilab's main injector corresponding to a total exposure of 7.01×10^{20} protons on target. We set upper limits at the 90% confidence level on the mixing parameter |U_{μ4}|^{2} in the mass ranges 10≤m_{HNL}≤150 MeV for the νe^{+}e^{-} channel and 150≤m_{HNL}≤245 MeV for the νπ^{0} channel, assuming |U_{e4}|^{2}=|U_{τ4}|^{2}=0. These limits represent the most stringent constraints in the mass range 35
Collapse
Affiliation(s)
- P Abratenko
- Tufts University, Medford, Massachusetts 02155, USA
| | - O Alterkait
- Tufts University, Medford, Massachusetts 02155, USA
| | - D Andrade Aldana
- Illinois Institute of Technology (IIT), Chicago, Illinois 60616, USA
| | - L Arellano
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - J Asaadi
- University of Texas, Arlington, Texas 76019, USA
| | - A Ashkenazi
- Tel Aviv University, Tel Aviv, Israel, 69978
| | - S Balasubramanian
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - B Baller
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - G Barr
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - D Barrow
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - J Barrow
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- Tel Aviv University, Tel Aviv, Israel, 69978
| | - V Basque
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | | | - S Berkman
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
- Michigan State University, East Lansing, Michigan 48824, USA
| | - A Bhanderi
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - A Bhat
- University of Chicago, Chicago, Illinois 60637, USA
| | - M Bhattacharya
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - M Bishai
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - A Blake
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - B Bogart
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - T Bolton
- Kansas State University (KSU), Manhattan, Kansas 66506, USA
| | - J Y Book
- Harvard University, Cambridge, Massachusetts 02138, USA
| | - M B Brunetti
- University of Warwick, Coventry CV4 7AL, United Kingdom
| | - L Camilleri
- Columbia University, New York, New York 10027, USA
| | - Y Cao
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - D Caratelli
- University of California, Santa Barbara, California 93106, USA
| | - F Cavanna
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - G Cerati
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - A Chappell
- University of Warwick, Coventry CV4 7AL, United Kingdom
| | - Y Chen
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J M Conrad
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Convery
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | | | - J I Crespo-Anadón
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid E-28040, Spain
| | - R Cross
- University of Warwick, Coventry CV4 7AL, United Kingdom
| | - M Del Tutto
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - S R Dennis
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - P Detje
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - A Devitt
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - R Diurba
- Universität Bern, Bern CH-3012, Switzerland
| | - Z Djurcic
- Argonne National Laboratory (ANL), Lemont, Illinois 60439, USA
| | - R Dorrill
- Illinois Institute of Technology (IIT), Chicago, Illinois 60616, USA
| | - K Duffy
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - S Dytman
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - B Eberly
- University of Southern Maine, Portland, Maine 04104, USA
| | - P Englezos
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - A Ereditato
- University of Chicago, Chicago, Illinois 60637, USA
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - J J Evans
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - R Fine
- Los Alamos National Laboratory (LANL), Los Alamos, New Mexico 87545, USA
| | - O G Finnerud
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - W Foreman
- Illinois Institute of Technology (IIT), Chicago, Illinois 60616, USA
| | - B T Fleming
- University of Chicago, Chicago, Illinois 60637, USA
| | - D Franco
- University of Chicago, Chicago, Illinois 60637, USA
| | - A P Furmanski
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - F Gao
- University of California, Santa Barbara, California 93106, USA
| | | | - S Gardiner
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - G Ge
- Columbia University, New York, New York 10027, USA
| | - S Gollapinni
- Los Alamos National Laboratory (LANL), Los Alamos, New Mexico 87545, USA
| | - E Gramellini
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - P Green
- University of Oxford, Oxford OX1 3RH, United Kingdom
| | - H Greenlee
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - L Gu
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - W Gu
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - R Guenette
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - P Guzowski
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - L Hagaman
- University of Chicago, Chicago, Illinois 60637, USA
| | - O Hen
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Hilgenberg
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | | | - Z Imani
- Tufts University, Medford, Massachusetts 02155, USA
| | - B Irwin
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - M Ismail
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C James
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - X Ji
- Nankai University, Nankai District, Tianjin 300071, China
| | - J H Jo
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - R A Johnson
- University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - Y-J Jwa
- Columbia University, New York, New York 10027, USA
| | - D Kalra
- Columbia University, New York, New York 10027, USA
| | - N Kamp
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G Karagiorgi
- Columbia University, New York, New York 10027, USA
| | - W Ketchum
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - M Kirby
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - T Kobilarcik
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - I Kreslo
- Universität Bern, Bern CH-3012, Switzerland
| | - M B Leibovitch
- University of California, Santa Barbara, California 93106, USA
| | - I Lepetic
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - J-Y Li
- University of Edinburgh, Edinburgh EH9 3FD, United Kingdom
| | - K Li
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - Y Li
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - K Lin
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - B R Littlejohn
- Illinois Institute of Technology (IIT), Chicago, Illinois 60616, USA
| | - H Liu
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - W C Louis
- Los Alamos National Laboratory (LANL), Los Alamos, New Mexico 87545, USA
| | - X Luo
- University of California, Santa Barbara, California 93106, USA
| | - C Mariani
- Center for Neutrino Physics, Virginia Tech, Blacksburg, Viriginia 24061, USA
| | - D Marsden
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - J Marshall
- University of Warwick, Coventry CV4 7AL, United Kingdom
| | - N Martinez
- Kansas State University (KSU), Manhattan, Kansas 66506, USA
| | - D A Martinez Caicedo
- South Dakota School of Mines and Technology (SDSMT), Rapid City, South Dakota 57701, USA
| | - S Martynenko
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - A Mastbaum
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - I Mawby
- University of Warwick, Coventry CV4 7AL, United Kingdom
| | - N McConkey
- University College London, London WC1E 6BT, United Kingdom
| | - V Meddage
- Kansas State University (KSU), Manhattan, Kansas 66506, USA
| | - J Micallef
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- Tufts University, Medford, Massachusetts 02155, USA
| | - K Miller
- University of Chicago, Chicago, Illinois 60637, USA
| | - A Mogan
- Colorado State University, Fort Collins, Colorado 80523, USA
| | - T Mohayai
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
- Indiana University, Bloomington, Indiana 47405, USA
| | - M Mooney
- Colorado State University, Fort Collins, Colorado 80523, USA
| | - A F Moor
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - C D Moore
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - L Mora Lepin
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - M M Moudgalya
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | | | - D Naples
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Navrer-Agasson
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - N Nayak
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - M Nebot-Guinot
- University of Edinburgh, Edinburgh EH9 3FD, United Kingdom
| | - J Nowak
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - N Oza
- Columbia University, New York, New York 10027, USA
| | - O Palamara
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - N Pallat
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - V Paolone
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A Papadopoulou
- Argonne National Laboratory (ANL), Lemont, Illinois 60439, USA
| | - V Papavassiliou
- New Mexico State University (NMSU), Las Cruces, New Mexico 88003, USA
| | - H B Parkinson
- University of Edinburgh, Edinburgh EH9 3FD, United Kingdom
| | - S F Pate
- New Mexico State University (NMSU), Las Cruces, New Mexico 88003, USA
| | - N Patel
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - Z Pavlovic
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - E Piasetzky
- Tel Aviv University, Tel Aviv, Israel, 69978
| | - I Pophale
- Lancaster University, Lancaster LA1 4YW, United Kingdom
| | - X Qian
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - J L Raaf
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - V Radeka
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - A Rafique
- Argonne National Laboratory (ANL), Lemont, Illinois 60439, USA
| | - M Reggiani-Guzzo
- University of Edinburgh, Edinburgh EH9 3FD, United Kingdom
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - L Ren
- New Mexico State University (NMSU), Las Cruces, New Mexico 88003, USA
| | - L Rochester
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Rodriguez Rondon
- South Dakota School of Mines and Technology (SDSMT), Rapid City, South Dakota 57701, USA
| | - M Rosenberg
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Ross-Lonergan
- Los Alamos National Laboratory (LANL), Los Alamos, New Mexico 87545, USA
| | | | - I Safa
- Columbia University, New York, New York 10027, USA
| | - G Scanavini
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - D W Schmitz
- University of Chicago, Chicago, Illinois 60637, USA
| | - A Schukraft
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - W Seligman
- Columbia University, New York, New York 10027, USA
| | - M H Shaevitz
- Columbia University, New York, New York 10027, USA
| | - R Sharankova
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - J Shi
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - E L Snider
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - M Soderberg
- Syracuse University, Syracuse, New York 13244, USA
| | | | - J Spitz
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - M Stancari
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - J St John
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - T Strauss
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - A M Szelc
- University of Edinburgh, Edinburgh EH9 3FD, United Kingdom
| | - W Tang
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - N Taniuchi
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - K Terao
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - C Thorpe
- Lancaster University, Lancaster LA1 4YW, United Kingdom
- The University of Manchester, Manchester M13 9PL, United Kingdom
| | - D Torbunov
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - D Totani
- University of California, Santa Barbara, California 93106, USA
| | - M Toups
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - Y-T Tsai
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Tyler
- Kansas State University (KSU), Manhattan, Kansas 66506, USA
| | - M A Uchida
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - T Usher
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - B Viren
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - M Weber
- Universität Bern, Bern CH-3012, Switzerland
| | - H Wei
- Louisiana State University, Baton Rouge, Louisiana 70803, USA
| | - A J White
- University of Chicago, Chicago, Illinois 60637, USA
| | - S Wolbers
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - T Wongjirad
- Tufts University, Medford, Massachusetts 02155, USA
| | - M Wospakrik
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - K Wresilo
- University of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - W Wu
- University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - E Yandel
- University of California, Santa Barbara, California 93106, USA
| | - T Yang
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - L E Yates
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - H W Yu
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| | - G P Zeller
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - J Zennamo
- Fermi National Accelerator Laboratory (FNAL), Batavia, Illinois 60510, USA
| | - C Zhang
- Brookhaven National Laboratory (BNL), Upton, New York 11973, USA
| |
Collapse
|
3
|
Nachira D, Bertoglio P, Ismail M, Napolitano AG, Calabrese G, Kuzmych K, Congedo MT, Sassorossi C, Meacci E, Petracca Ciavarella L, Chiappetta M, Lococo F, Solli P, Margaritora S. Are the Efficacy and Safety of Chest Tubes in Uniportal Video-Assisted Thoracic Surgery Related to the Level of Intercostal Space Insertion or to the Drain Type? A Prospective Multicenter Study. J Clin Med 2024; 13:430. [PMID: 38256564 PMCID: PMC10817031 DOI: 10.3390/jcm13020430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 01/02/2024] [Accepted: 01/10/2024] [Indexed: 01/24/2024] Open
Abstract
OBJECTIVES The aim of this study is to evaluate if the efficacy and safety of chest tube placement are influenced by the level of intercostal space insertion (uniportal VATS vs. biportal VATS) or by the type of drain employed (standard vs. smart coaxial drain). METHODS Data on patients who underwent either uniportal or biportal VATS upper lobectomies with lymphadenectomy were prospectively collected in three European centers. The uniportal VATS group with a 28 Fr standard chest tube (U-VATS standard) was compared with the uniportal VATS group with a 28 Fr smart drain (U-VATS smart), and U-VATS smart was also compared with biportal VATS with a 28 Fr smart drain inserted in the VIII intercostal space (Bi-VATS smart). RESULTS When comparing the U-VATS standard group with the U-VATS smart, a higher fluid output was recorded in the U-VATS smart (p: 0.004) in the III post-operative day (p.o.) and overall (p: 0.027), with a lower 90-day re-admission in the U-VATS smart (p: 0.04). The Bi-VATS smart group compared to U-VATS smart showed a higher fluid output in the I p.o. (p < 0.001), with no difference in total fluid amount or hospitalization. The Bi-VATS smart recorded a lower incidence (p < 0.001) of residual pleural space or effusion (p: 0.004) at chest X-rays prior to drain removal but a higher level of pain and chronic intercostal neuralgia (p: 0.03). CONCLUSIONS Chest tube insertion through the same incision space in uniportal VATS seems to be safe and effective. Smart drains can improve the fluid output in uniportal VATS, as if the drainage were inserted in a lower space (i.e., biportal VATS), but with less discomfort.
Collapse
Affiliation(s)
- Dania Nachira
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Pietro Bertoglio
- Division of Thoracic Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy
| | - Mahmoud Ismail
- Division of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin, Humboldt University Berlin, 14467 Potsdam, Germany;
| | - Antonio Giulio Napolitano
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Giuseppe Calabrese
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Khrystyna Kuzmych
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Maria Teresa Congedo
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Carolina Sassorossi
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Elisa Meacci
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Leonardo Petracca Ciavarella
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Marco Chiappetta
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Filippo Lococo
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| | - Piergiorgio Solli
- Division of Thoracic Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy
| | - Stefano Margaritora
- Department of Thoracic Surgery, Fondazione Policlinico Universitario “A.Gemelli” IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; (A.G.N.); (G.C.); (M.T.C.); (E.M.); (L.P.C.); (M.C.); (F.L.); (S.M.)
| |
Collapse
|
4
|
Zhou Y, Leahy K, Grose A, Lykins J, Siddiqui M, Leong N, Goodall P, Withers S, Ashi K, Schrantz S, Tesic V, Abeleda AP, Beavis K, Clouser F, Ismail M, Christmas M, Piarroux R, Limonne D, Chapey E, Abraham S, Baird I, Thibodeau J, Boyer K, Torres E, Conrey S, Wang K, Staat MA, Back N, Gomez Marin J, Peyron F, Houze S, Wallon M, McLeod R. Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more. medRxiv 2023:2023.04.26.23289132. [PMID: 37162985 PMCID: PMC10168490 DOI: 10.1101/2023.04.26.23289132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
Background Congenital toxoplasmosis is a treatable, preventable disease, but untreated causes death, prematurity, loss of sight, cognition and motor function, and substantial costs worldwide. Methods/Findings In our ongoing USA feasibility/efficacy clinical trial, data collated with other ongoing and earlier published results proved high performance of an Immunochromatographic-test(ICT) that enables accurate, rapid diagnosis/treatment, establishing new paradigms for care. Overall results from patient blood and/or serum samples tested with ICT compared with gold-standard-predicate-test results found ICT performance for 4606 sera/1876 blood, 99.3%/97.5% sensitive and 98.9%/99.7% specific. However, in the clinical trial the FDA-cleared-predicate test initially caused practical, costly problems due to false-positive-IgM results. For 58 persons, 3/43 seronegative and 2/15 chronically infected persons had false positive IgM predicate tests. This caused substantial anxiety, concerns, and required costly, delayed confirmation in reference centers. Absence of false positive ICT results contributes to solutions: Lyon and Paris France and USA Reference laboratories frequently receive sera with erroneously positive local laboratory IgM results impeding patient care. Therefore, thirty-two such sera referred to Lyon's Reference laboratory were ICT-tested. We collated these with other earlier/ongoing results: 132 of 137 USA or French persons had false positive local laboratory IgM results identified correctly as negative by ICT. Five false positive ICT results in Tunisia and Marseille, France, emphasize need to confirm positive ICT results with Sabin-Feldman-Dye-test or western blot. Separate studies demonstrated high performance in detecting acute infections, meeting FDA, CLIA, WHO ASSURED, CEMark criteria and patient and physician satisfaction with monthly-gestational-ICT-screening. Conclusions/Significance This novel paradigm using ICT identifies likely false positives or raises suspicion that a result is truly positive, rapidly needing prompt follow up and treatment. Thus, ICT enables well-accepted gestational screening programs that facilitate rapid treatment saving lives, sight, cognition and motor function. This reduces anxiety, delays, work, and cost at point-of-care and clinical laboratories. Author’s Summary Toxoplasmosis is a major health burden for developed and developing countries, causing damage to eyes and brain, loss of life and substantial societal costs. Prompt diagnosis in gestational screening programs enables treatment, thereby relieving suffering, and leading to > 14-fold cost savings for care. Herein, we demonstrate that using an ICT that meets WHO ASSURED-criteria identifying persons with/without antibody to Toxoplasma gondii in sera and whole blood with high sensitivity and specificity, is feasible to use in USA clinical practice. We find this new approach can help to obviate the problem of detection of false positive anti- T.gondii IgM results for those without IgG antibodies to T.gondii when this occurs in present, standard of care, predicate USA FDA cleared available assays. Thus, this accurate test facilitates gestational screening programs and a global initiative to diagnose and thereby prevent and treat T.gondii infection. This minimizes likelihood of false positives (IgG and/or IgM) while maintaining maximum sensitivity. When isolated IgM antibodies are detected, it is necessary to confirm and when indicated continue follow up testing in ∼2 weeks to establish seroconversion. Presence of a positive ICT makes it likely that IgM is truly positive and a negative ICT makes it likely that IgM will be a false positive without infection. These results create a new, enthusiastically-accepted, precise paradigm for rapid diagnosis and validation of results with a second-line test. This helps eliminate alarm and anxiety about false-positive results, while expediting needed treatment for true positive results and providing back up distinguishing false positive tests.
Collapse
|
5
|
Ismail M, Awadein A. Palpebral Fissure Changes in the Contralateral Eye in Duane Retraction Syndrome. J Pediatr Ophthalmol Strabismus 2023; 60:e22-e25. [PMID: 37227993 DOI: 10.3928/01913913-20230217-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Duane retraction syndrome (DRS) is a congenital cranial dysinnervation disorder that is characterized by paradoxical lateral rectus muscle innervation of the affected eye by axons meant to innervate the ipsilateral medial rectus muscle, with resultant varying degrees of co-contraction. It is characterized by severe abduction deficiency, variable limitation of adduction, globe retraction with narrowing of the palpebral fissure, and oblique elevation or depression on adduction. A total of 16 patients with unilateral DRS were identified. The mean age was 13 ± 8 years (range: 6 to 28 years). There were 5 males and 11 females. The cohort included 8 patients with DRS type I, 3 patients with DRS type II, 4 patients with DRS type III, and 1 patient with synergistic divergence (DRS type IV). The mean width of the palpebral fissure in primary gaze was 9.95 ± 0.25 mm, increased in abduction to 11.11 ± 1.16 mm, and changed on adduction to 10.03 ± 1.19 mm. The mean reduction in the size of the palpebral fissure on adduction was 11.7 ± 10.2% (range: 0 to 30%). The difference in the palpebral fissure width between adduction and abduction was statistically significant (P = .0018). Of the 16 patients, 8 (50%) showed narrowing of the palpebral fissure of the contralateral eye on adduction compared to abduction of more than 10%. In this case series of unilateral Duane retraction syndrome, there was a common association between widening of the palpebral fissure of the unaffected eye and adduction of the eyes with DRS in DRS types II, III, and IV and DRS type I with upshoot or downshoot. [J Pediatr Ophthalmol Strabismus. 2023;60(3):e22-e25.].
Collapse
|
6
|
Ismail M, Waterhouse BR, Colman A, Gonzalez-Rivas D, Bosinceanu M, Dunning J. The transition to uniportal robotic surgery in the second decade of uniportal surgery. Ann Cardiothorac Surg 2023; 12:96-101. [PMID: 37035643 PMCID: PMC10080332 DOI: 10.21037/acs-2022-urats-34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 03/08/2023] [Indexed: 03/30/2023]
Abstract
Uniportal robotic surgery was created by Dr. Diego Gonzalez-Rivas as a fusion of his decade of experience with uniportal video-assisted thoracoscopic surgery (VATS) and his recent experience with the Intuitive Robotic System. It represents, in his view, the natural evolution of the uniportal technique in the era of robotic surgery. In this article, we discuss some of the novel issues that this raises, including capacitive coupling, and we describe the technique in detail to help surgeons who may be interested in starting uniportal robotic surgery. We go through case selection, which should start with wedge resections and lymphadenectomy. We look at port placement, which is more posterior and lower than the usual uniportal VATS approach, and we discuss the optimal instruments and ports for the technique. We discuss the role of the assistant in uniportal robotic surgery, which is a key part of the operation as we regard this as a two-surgeon technique. We then discuss the future and other possible robotic platforms that might be suitable for uniportal robotic surgery. It is an exciting new development for robotic surgery, and we recommend that this technique is suitable for advanced surgeons who are experienced in uniportal VATS lobectomy and in multiportal robotic surgery.
Collapse
Affiliation(s)
| | | | - Alyx Colman
- Department of Thoracic Surgery, James Cook University Hospital, Middlesbrough, UK
| | - Diego Gonzalez-Rivas
- Department of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit (UCTMI), Coruña University Hospital, A Coruña, Spain
| | - Mugurel Bosinceanu
- Department of Thoracic Surgery, Monza Oncological Hospital, Bucharest, Bulgaria
| | - Joel Dunning
- Department of Thoracic Surgery, James Cook University Hospital, Middlesbrough, UK
| |
Collapse
|
7
|
Manolache V, Motas N, Bosinceanu ML, de la Torre M, Gallego-Poveda J, Dunning J, Ismail M, Turna A, Paradela M, Decker G, Ramos R, Bodner J, Espinosa Jimenez D, Zardo P, Garcia-Perez A, Ureña Lluveras A, Pantile D, Gonzalez-Rivas D. Comparison of uniportal robotic-assisted thoracic surgery pulmonary anatomic resections with multiport robotic-assisted thoracic surgery: a multicenter study of the European experience. Ann Cardiothorac Surg 2023; 12:102-109. [PMID: 37035654 PMCID: PMC10080339 DOI: 10.21037/acs-2022-urats-27] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 02/17/2023] [Indexed: 03/12/2023]
Abstract
Background Robotic-assisted thoracic surgery (RATS) has seen increasing interest in the last few years, with most procedures primarily being performed in the conventional multiport manner. Our team has developed a new approach that has the potential to convert surgeons from uniportal video-assisted thoracic surgery (VATS) or open surgery to robotic-assisted surgery, uniportal-RATS (U-RATS). We aimed to evaluate the outcomes of one single incision, uniportal robotic-assisted thoracic surgery (U-RATS) against standard multiport RATS (M-RATS) with regards to safety, feasibility, surgical technique, immediate oncological result, postoperative recovery, and 30-day follow-up morbidity and mortality. Methods We performed a large retrospective multi-institutional review of our prospectively curated database, including 101 consecutive U-RATS procedures performed from September 2021 to October 2022, in the European centers that our main surgeon operates in. We compared these cases to 101 consecutive M-RATS cases done by our colleagues in Barcelona between 2019 to 2022. Results Both patient groups were similar with respect to demographics, smoking status and tumor size, but were significantly younger in the U-RATS group [M-RATS =69 (range, 39-81) years; U-RATS =63 years (range, 19-82) years; P<0.0001]. Most patients in both operative groups underwent resection of a primary non-small cell lung cancer (NSCLC) [M-RATS 96/101 (95%); U-RATS =60/101 (59%); P<0.0001]. The main type of anatomic resection was lobectomy for the multiport group, and segmentectomy for the U-RATS group. In the M-RATS group, only one anatomical segmentectomy was performed, while the U-RATS group had twenty-four (24%) segmentectomies (P=0.0006). All M-RATS and U-RATS surgical specimens had negative resection margins (R0) and contained an equivalent median number of lymph nodes available for pathologic analysis [M-RATS =11 (range, 5-54); U-RATS =15 (range, 0-41); P=0.87]. Conversion rate to thoracotomy was zero in the U-RATS group and low in M-RATS [M-RATS =2/101 (2%); U-RATS =0/101; P=0.19]. Median operative time was also statistically different [M-RATS =150 (range, 60-300) minutes; U-RATS =136 (range, 30-308) minutes; P=0.0001]. Median length of stay was significantly lower in U-RATS group at four days [M-RATS =5 (range, 2-31) days; U-RATS =4 (range, 1-18) days; P<0.0001]. Rate of complications and 30-day mortality was low in both groups. Conclusions U-RATS is feasible and safe for anatomic lung resections and comparable to the multiport conventional approach regarding surgical outcomes. Given the similarity of the technique to uniportal VATS, it presents the potential to convert minimally invasive thoracic surgeons to a robotic-assisted approach.
Collapse
Affiliation(s)
- Veronica Manolache
- Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania
- University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
| | - Natalia Motas
- Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania
- University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
- Department of Thoracic Surgery, Institute of Oncology “Prof. Dr. Al. Trestioreanu”, Bucharest, Romania
| | | | | | | | - Joel Dunning
- Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Akif Turna
- Department of Thoracic Surgery, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, İstanbul, Turkey
| | - Marina Paradela
- Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain
| | - Georges Decker
- Department of Thoracic Surgery, Hôpitaux Robert Schuman-ZithaKlinik, Luxembourg, Luxembourg
| | - Ricard Ramos
- Thoracic Surgery Service, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - Johanes Bodner
- Department of Thoracic Surgery, Klinikum Bogenhausen, Englschalkinger Strasse 77, Munchen, Germany
| | | | - Patrick Zardo
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | | | - Anna Ureña Lluveras
- Thoracic Surgery Service, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - Daniel Pantile
- Department of Thoracic Surgery, Central Military Emergency University Hospital Bucharest, Bucharest, Romania
| | - Diego Gonzalez-Rivas
- Department of Thoracic Surgery, Memorial Oncology Hospital, Bucharest, Romania
- Department of Thoracic Surgery, Coruña University Hospital, A Coruña, Spain
- Department of Cardio-Thoracic Surgery, Lusiadas Hospital, Lisbon, Portugal
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| |
Collapse
|
8
|
Ismail M, Waterhouse BR, Colman A, Gonzalez-Rivas D, Dunning J. Video atlas of each uniportal robotic-assisted thoracic surgery lobectomy and lymphadenectomy. Ann Cardiothorac Surg 2023; 12:91-95. [PMID: 37035651 PMCID: PMC10080340 DOI: 10.21037/acs-2022-urats-33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Accepted: 03/10/2023] [Indexed: 03/31/2023]
Abstract
It is important when evaluating new techniques that a surgeon can see and assess all the differences and similarities between their usual technique and the novel technique. Thus, we have collated a comprehensive atlas of videos of uniportal robotic lobectomies for every lobe. Surgeons who are considering embarking on a program of uniportal robotic lobectomies can accordingly see the different views and techniques that will be required for when they perform their first procedure. We have fully narrated the videos, so that you will be taken through each procedure. Whilst these five videos are fifty-five minutes in total, our intention is not necessarily for you to watch them all from start to finish, but rather, come to this video, select the lobe that you will shortly embark on, and watch it prior to your case so that you can visualise, as closely as possible, the procedure that you will be performing. We recommend that you watch the videos with your bedside assistant as the uniportal robotic lobectomy is a joint procedure between two surgeons, rather than a single surgeon's operation with an assistant. Though we have not provided videos on segmentectomies, the uniportal robotic lobectomy is an advanced technique and we are confident that advanced surgeons will be able to gain key insights with what has been included, even if they are proceeding to a segmentectomy for their first cases. We feel for an advanced surgeon, a segmentectomy will be just as suitable an operation as a lobectomy in the initial learning phase.
Collapse
Affiliation(s)
| | | | - Alyx Colman
- Department of Thoracic Surgery, James Cook University Hospital, Middlesbrough, UK
| | - Diego Gonzalez-Rivas
- Department of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit (UCTMI), Coruña University Hospital, A Coruña, Spain
| | - Joel Dunning
- Department of Thoracic Surgery, James Cook University Hospital, Middlesbrough, UK
| |
Collapse
|
9
|
Ismail M, El-Hefnawy A, Shoma A, Elzalouey E. Tadalafil versus combined tamsolusin and ciprofloxacin for treatment of chronic pelvic pain syndrome: A randomized controlled trial. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00197-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
10
|
Buchfuhrer M, Baker F, Singh H, Kolotovska V, Adlou B, Anand H, de Zambotti M, Ismail M, Raghunathan S, Charlesworth J. Noninvasive peroneal nerve stimulation reduces symptoms of Restless Legs Syndrome. Sleep Med 2022. [DOI: 10.1016/j.sleep.2022.05.621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
11
|
Blakeway H, Amin‐Chowdhury Z, Prasad S, Kalafat E, Ismail M, Abdallah FN, Rezvani A, Amirthalingam G, Brown K, Le Doare K, Heath PT, Ladhani SN, Khalil A. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women. Ultrasound Obstet Gynecol 2022; 60:673-680. [PMID: 36318630 PMCID: PMC9538835 DOI: 10.1002/uog.26050] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 07/22/2022] [Accepted: 07/29/2022] [Indexed: 05/13/2023]
Abstract
OBJECTIVE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with increased risk of adverse maternal and perinatal outcomes. Vaccines are highly effective at preventing severe coronavirus disease 2019 (COVID-19), but there are limited data on COVID-19 vaccines in pregnancy. This study aimed to investigate the reactogenicity and immunogenicity of COVID-19 vaccines in pregnant women when administered according to the 12-week-interval dosing schedule recommended in the UK. METHODS This was a cohort study of pregnant women receiving COVID-19 vaccination between April and September 2021. The outcomes were immunogenicity and reactogenicity after COVID-19 vaccination. Pregnant women were recruited by phone, e-mail and/or text and were vaccinated according to vaccine availability at their local vaccination center. For immunogenicity assessment, blood samples were taken at specific timepoints after each dose to evaluate nucleocapsid protein (N) and spike protein (S) antibody titers. The comparator group comprised non-pregnant female healthcare workers in the same age group who were vaccinated as part of the national immunization program in a contemporaneous longitudinal cohort study. Longitudinal changes in serum antibody titers and association with pregnancy status were assessed using a two-step regression approach. Reactogenicity assessment in pregnant women was undertaken using an online questionnaire. The comparator group comprised non-pregnant women aged 18-49 years who had received two vaccine doses in primary care. The association of pregnancy status with reactogenicity was assessed using logistic regression analysis. RESULTS Overall, 67 pregnant women, of whom 66 had received a mRNA vaccine, and 79 non-pregnant women, of whom 50 had received a mRNA vaccine, were included in the immunogenicity study. Most (61.2%) pregnant women received their first vaccine dose in the third trimester, while 3.0% received it in the first trimester and 35.8% in the second trimester. SARS-CoV-2 S-antibody geometric mean concentrations after mRNA vaccination were not significantly different at 2-6 weeks after the first dose but were significantly lower at 2-6 weeks after the second dose in infection-naïve pregnant compared with non-pregnant women. In pregnant women, prior infection was associated with higher antibody levels at 2-6 weeks after the second vaccine dose. Reactogenicity analysis included 108 pregnant women and 116 non-pregnant women. After the first dose, tiredness and chills were reported less commonly in pregnant compared with non-pregnant women (P = 0.043 and P = 0.029, respectively). After the second dose, feeling generally unwell was reported less commonly (P = 0.046) in pregnant compared with non-pregnant women. CONCLUSIONS Using an extended 12-week interval between vaccine doses, antibody responses after two doses of mRNA COVID-19 vaccine were found to be lower in pregnant compared with non-pregnant women. Strong antibody responses were achieved after one dose in previously infected women, regardless of pregnancy status. Pregnant women reported fewer adverse events after both the first and second dose of vaccine. These findings should now be addressed in larger controlled studies. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- H. Blakeway
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
| | - Z. Amin‐Chowdhury
- Immunisation and Vaccine Preventable Diseases DivisionUK Health Security Agency (previously known as Public Health England)LondonUK
| | - S. Prasad
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
| | - E. Kalafat
- Koc University, School of Medicine, Department of Obstetrics and GynecologyIstanbulTurkey
- Department of Statistics, Faculty of Arts and SciencesMiddle East Technical UniversityAnkaraTurkey
| | - M. Ismail
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
| | - F. N. Abdallah
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
| | - A. Rezvani
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
| | - G. Amirthalingam
- Immunisation and Vaccine Preventable Diseases DivisionUK Health Security Agency (previously known as Public Health England)LondonUK
| | - K. Brown
- Immunisation and Vaccine Preventable Diseases DivisionUK Health Security Agency (previously known as Public Health England)LondonUK
| | - K. Le Doare
- Centre for Neonatal and Paediatric Infection and Vaccine Institute, Institute of Infection and Immunity, St George's University of LondonLondonUK
| | - P. T. Heath
- Centre for Neonatal and Paediatric Infection and Vaccine Institute, Institute of Infection and Immunity, St George's University of LondonLondonUK
| | - S. N. Ladhani
- Immunisation and Vaccine Preventable Diseases DivisionUK Health Security Agency (previously known as Public Health England)LondonUK
- Centre for Neonatal and Paediatric Infection and Vaccine Institute, Institute of Infection and Immunity, St George's University of LondonLondonUK
| | - A. Khalil
- Fetal Medicine Unit, St George's Hospital, St George's University of LondonLondonUK
- Vascular Biology Research CentreMolecular and Clinical Sciences Research Institute, St George's University of LondonLondonUK
| |
Collapse
|
12
|
Felín MS, Wang K, Raggi C, Moreira A, Pandey A, Grose A, Caballero Z, Rengifo-Herrera C, Ramirez M, Moossazadeh D, Castro C, Montalvo JLS, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Norero X, Estripeaut D, Ellis D, Ashi K, Dovgin S, Dixon A, Li X, Begeman I, Heichman S, Lykins J, Villalobos-Cerrud D, Fabrega L, Mendivil C, Quijada MR, Fernández-Pirla S, de La Guardia V, Wong D, de LadrónGuevara M, Flores C, Borace J, García A, Caballero N, de Saez MTM, Politis M, Ross S, Dogra M, Dhamsania V, Graves N, Kirchberg M, Mathur K, Aue A, Restrepo CM, Llanes A, Guzman G, Rebollon A, Boyer K, Heydemann P, Noble AG, Swisher C, Rabiah P, Withers S, Hull T, Su C, Blair M, Latkany P, Mui E, Vasconcelos-Santos DV, Villareal A, Perez A, Galvis CAN, Montes MV, Perez NIC, Ramirez M, Chittenden C, Wang E, Garcia-López LL, Muñoz-Ortiz J, Rivera-Valdivia N, Bohorquez-Granados MC, de-la-Torre GC, Padrieu G, Hernandez JDV, Celis-Giraldo D, Acosta Dávila JA, Torres E, Oquendo MM, Arteaga-Rivera JY, Nicolae D, Rzhetsky A, Roizen N, Stillwaggon E, Sawers L, Peyron F, Wallon M, Chapey E, Levigne P, Charter C, De Frias M, Montoya J, Press C, Ramirez R, Contopoulos-Ioannidis D, Maldonado Y, Liesenfeld O, Gomez C, Wheeler K, Holfels E, Frim D, McLone D, Penn R, Cohen W, Zehar S, McAuley J, Limonne D, Houze S, Abraham S, Piarroux R, Tesic V, Beavis K, Abeleda A, Sautter M, El Mansouri B, El Bachir A, Amarir F, El Bissati K, de-la-Torre A, Britton G, Motta J, Ortega-Barria E, Romero IL, Meier P, Grigg M, Gómez-Marín J, Kosagisharaf JR, Llorens XS, Reyes O, McLeod R. Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors. Curr Pediatr Rep 2022; 10:109-124. [PMID: 37744780 PMCID: PMC10516319 DOI: 10.1007/s40124-022-00265-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/29/2022] [Indexed: 11/25/2022]
Abstract
Purpose of Review Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.
Collapse
Affiliation(s)
| | - Kanix Wang
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Catalina Raggi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Aliya Moreira
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Abhinav Pandey
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Andrew Grose
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Zuleima Caballero
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | - Margarita Ramirez
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Davina Moossazadeh
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Catherine Castro
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - José Luis Sanchez Montalvo
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Karen Leahy
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ying Zhou
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Maryam Siddiqui
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Nicole Leong
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Perpetua Goodall
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Morgan Michalowski
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mahmoud Ismail
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Monica Christmas
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Stephen Schrantz
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ximena Norero
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Dora Estripeaut
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - David Ellis
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Kevin Ashi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Samantha Dovgin
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Ashtyn Dixon
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Xuan Li
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Ian Begeman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Sharon Heichman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Joseph Lykins
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Delba Villalobos-Cerrud
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Lorena Fabrega
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Connie Mendivil
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Mario R. Quijada
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Silvia Fernández-Pirla
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
- Academia Interamericana de Panamá, Ciudad de
Panamá, Panama
| | - Valli de La Guardia
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Digna Wong
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Mayrene de LadrónGuevara
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | | | - Anabel García
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | - Maria Theresa Moreno de Saez
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
| | - Michael Politis
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
| | - Stephanie Ross
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Mimansa Dogra
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Vishan Dhamsania
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Nicholas Graves
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Marci Kirchberg
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Kopal Mathur
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Ashley Aue
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Carlos M. Restrepo
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Alejandro Llanes
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - German Guzman
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Arturo Rebollon
- Sanofi Aventis de Panamá S.A, University of South
Florida, Ciudad de Panamá, Panama
| | - Kenneth Boyer
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Peter Heydemann
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - A. Gwendolyn Noble
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Charles Swisher
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | | | - Shawn Withers
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Teri Hull
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Chunlei Su
- Department of Microbiology, The University of Tennessee,
Knoxville, TN, USA
| | - Michael Blair
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Paul Latkany
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ernest Mui
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Alcibiades Villareal
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Ambar Perez
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | | | | | | | - Morgan Ramirez
- The College, The University of Chicago, Chicago, IL,
USA
| | - Cy Chittenden
- The College, The University of Chicago, Chicago, IL,
USA
| | - Edward Wang
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Juliana Muñoz-Ortiz
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | - Guillermo Padrieu
- The University of South Florida College of Public Health,
Tampa, FL, USA
| | | | - Daniel Celis-Giraldo
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | - Elizabeth Torres
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | - Dan Nicolae
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Andrey Rzhetsky
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Nancy Roizen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Larry Sawers
- Department of Economics, American University, Washington,
D.C, USA
| | - Francois Peyron
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Martine Wallon
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Emanuelle Chapey
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | - Pauline Levigne
- Institut Des Agents Infectieux, Hôpital de La
Croix-Rousse, Lyon, France
| | | | | | - Jose Montoya
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | - Cindy Press
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | | | - Despina Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | | | - Carlos Gomez
- Department of Economics, Gettysburg College, Gettysburg,
PA, USA
| | - Kelsey Wheeler
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ellen Holfels
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David Frim
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David McLone
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Richard Penn
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - William Cohen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Samantha Zehar
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - James McAuley
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Sandrine Houze
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | - Sylvie Abraham
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | | | - Vera Tesic
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Kathleen Beavis
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ana Abeleda
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mari Sautter
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | | | - Fatima Amarir
- Faculty of Sciences Aïn Chok, University Hassan
II, Casablanca, Morocco
| | - Kamal El Bissati
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- INH, Rabat, Morocco
| | | | - Gabrielle Britton
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Jorge Motta
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
| | - Eduardo Ortega-Barria
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
- GSK Vaccines, Panamá, Panama
| | - Isabel Luz Romero
- Tecnología E Innovación (SENACYT),
Secretaría Nacional de Ciencia, Ciudad de Panamá, Panama
| | - Paul Meier
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Michael Grigg
- Molecular Parasitology Section Laboratory of Parasitic
Diseases, National Institutes of Health, NIAID, Bethesda, MD, USA
| | | | - Jagannatha Rao Kosagisharaf
- Instituto de Investigaciones Científicas Y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Ciudad de Panamá, Panama
| | - Xavier Sáez Llorens
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Ciudad de Panamá, Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Osvaldo Reyes
- Academia Interamericana de Panamá, Ciudad de
Panamá, Panama
- Hospital Santo Tomás, Ciudad de Panamá,
Panama
- Sistema Nacional de Investigadores de Panamá
(SNI), Clayton, Panama
| | - Rima McLeod
- Toxoplasmosis Programs and Initiatives in Panamá,
Ciudad de Panamá, Panama
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Toxoplasmosis Center, The University of Chicago, and
Toxoplasmosis Research Institute, Chicago, IL, USA
- Department of Pediatrics (Infectious Diseases), The
University of Chicago, Chicago, IL, USA
| |
Collapse
|
13
|
Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Caballero Z, Norero X, Estripeaut D, Ellis D, Raggi C, Castro C, Rengifo-Herrera C, Moossazadeh D, Ramirez M, Pandey A, Ashi K, Dovgin S, Dixon A, Li X, Begeman I, Heichman S, Lykins J, Villalobos-Cerrud D, Fabrega L, Montalvo JLS, Mendivil C, Quijada MR, Fernández-Pirla S, de La Guardia V, Wong D, de Guevara ML, Flores C, Borace J, García A, Caballero N, de Saez MTM, Politis M, Ross S, Dogra M, Dhamsania V, Graves N, Kirchberg M, Mathur K, Aue A, Restrepo CM, Llanes A, Guzman G, Rebellon A, Boyer K, Heydemann P, Noble AG, Swisher C, Rabiah P, Withers S, Hull T, Frim D, McLone D, Su C, Blair M, Latkany P, Mui E, Vasconcelos-Santos DV, Villareal A, Perez A, Galvis CAN, Montes MV, Perez NIC, Ramirez M, Chittenden C, Wang E, Garcia-López LL, Muñoz-Ortiz J, Rivera-Valdivia N, Bohorquez-Granados MC, de-la-Torre GC, Padrieu G, Hernandez JDV, Celis-Giraldo D, Dávila JAA, Torres E, Oquendo MM, Arteaga-Rivera JY, Nicolae DL, Rzhetsky A, Roizen N, Stillwaggon E, Sawers L, Peyron F, Wallon M, Chapey E, Levigne P, Charter C, De Frias M, Montoya J, Press C, Ramirez R, Contopoulos-Ioannidis D, Maldonado Y, Liesenfeld O, Gomez C, Wheeler K, Zehar S, McAuley J, Limonne D, Houze S, Abraham S, Piarroux R, Tesic V, Beavis K, Abeleda A, Sautter M, El Mansouri B, El Bachir A, Amarir F, El Bissati K, Holfels E, Penn R, Cohen W, de-la-Torre A, Britton G, Motta J, Ortega-Barria E, Romero IL, Meier P, Grigg M, Gómez-Marín J, Kosagisharaf JR, Llorens XS, Reyes O, McLeod R. Building Programs to Eradicate Toxoplasmosis Part II: Education. Curr Pediatr Rep 2022; 10:93-108. [PMID: 36969368 PMCID: PMC10035399 DOI: 10.1007/s40124-022-00267-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Abstract
Purpose of Review
Review work to create and evaluate educational materials that could serve as a primary prevention strategy to help both providers and patients in Panama, Colombia, and the USA reduce disease burden of Toxoplasma infections.
Recent Findings
Educational programs had not been evaluated for efficacy in Panama, USA, or Colombia.
Summary
Educational programs for high school students, pregnant women, medical students and professionals, scientists, and lay personnel were created. In most settings, short-term effects were evaluated. In Panama, Colombia, and USA, all materials showed short-term utility in transmitting information to learners. These educational materials can serve as a component of larger public health programs to lower disease burden from congenital toxoplasmosis. Future priorities include conducting robust longitudinal studies of whether education correlates with reduced adverse disease outcomes, modifying educational materials as new information regarding region-specific risk factors is discovered, and ensuring materials are widely accessible.
Collapse
Affiliation(s)
| | - Kanix Wang
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Aliya Moreira
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Andrew Grose
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Karen Leahy
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ying Zhou
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Maryam Siddiqui
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Nicole Leong
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Perpetua Goodall
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Morgan Michalowski
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mahmoud Ismail
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Monica Christmas
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Stephen Schrantz
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Zuleima Caballero
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Ximena Norero
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Dora Estripeaut
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - David Ellis
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Catalina Raggi
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Catherine Castro
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Claudia Rengifo-Herrera
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Universidad de Panamá, Panama City, Panama
| | - Davina Moossazadeh
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Margarita Ramirez
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Abhinav Pandey
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Kevin Ashi
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Samantha Dovgin
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Ashtyn Dixon
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Xuan Li
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Ian Begeman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Sharon Heichman
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Joseph Lykins
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Delba Villalobos-Cerrud
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Lorena Fabrega
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - José Luis Sanchez Montalvo
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Connie Mendivil
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Mario R. Quijada
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Silvia Fernández-Pirla
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Academia Interamericana de Panamá, Panama City,
Panama
- Hospital Santo Tomás, Panama City, Panama
| | - Valli de La Guardia
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
- Hospital San Miguel de Arcangel, Ciudad de Panama,
Panama
| | - Digna Wong
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Mayrene Ladrón de Guevara
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
| | | | | | - Anabel García
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | | | - Maria Theresa Moreno de Saez
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
| | - Michael Politis
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
| | - Stephanie Ross
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Mimansa Dogra
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
| | - Vishan Dhamsania
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Nicholas Graves
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
| | - Marci Kirchberg
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Kopal Mathur
- Capstone Program, Global Health Center, The University of
Chicago, Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Ashley Aue
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Harris School of Public Policy, The University of
Chicago, Chicago, IL, USA
| | - Carlos M. Restrepo
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Alejandro Llanes
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - German Guzman
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Arturo Rebellon
- Sanofi Aventis de Panamá S.A., University of South
Florida, Panama City, Panama
| | - Kenneth Boyer
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - Peter Heydemann
- Rush University Medical School/Rush University Medical
Center, Chicago, IL, USA
| | - A. Gwendolyn Noble
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Charles Swisher
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Peter Rabiah
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- NorthShore Evanston Hospital, Evanston, IL, USA
| | - Shawn Withers
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Teri Hull
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David Frim
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - David McLone
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - Chunlei Su
- Department of Microbiology, The University of Tennessee,
Knoxville, TN, USA
| | - Michael Blair
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Paul Latkany
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Ernest Mui
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Alcibiades Villareal
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | - Ambar Perez
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
| | | | | | | | - Morgan Ramirez
- The College, The University of Chicago, Chicago, IL,
USA
| | - Cy Chittenden
- The College, The University of Chicago, Chicago, IL,
USA
| | - Edward Wang
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Juliana Muñoz-Ortiz
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | - Guillermo Padrieu
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Grupo de Investigación en Neurociencias,
Universidad del Rosario, Bogotá, Colombia
| | | | | | | | | | | | | | - Dan L. Nicolae
- Department of Statistics, The University of Chicago,
Chicago, IL, USA
| | - Andrey Rzhetsky
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
| | - Nancy Roizen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | | | - Larry Sawers
- Department of Economics, American University, D,
Washington .C, USA
| | - Francois Peyron
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Martine Wallon
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Emanuelle Chapey
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | - Pauline Levigne
- Institut des agents infectieux, Hôpital de la
Croix-Rousse, Lyon, France
| | | | | | - Jose Montoya
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | - Cindy Press
- Remington Specialty Laboratory, Palo Alto, CA, USA
| | | | - Despina Contopoulos-Ioannidis
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Yvonne Maldonado
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | | | - Carlos Gomez
- Department of Pediatrics, Division of Infectious
Diseases, Stanford University College of Medicine, Stanford, CA, USA
| | - Kelsey Wheeler
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | - Samantha Zehar
- Northwestern University Feinberg School of Medicine,
Chicago, IL, USA
| | - James McAuley
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | - Sandrine Houze
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | - Sylvie Abraham
- Laboratory of Parasitologie, Bichat-Claude Bernard
Hopital, Paris, France
| | | | - Vera Tesic
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Kathleen Beavis
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Ana Abeleda
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Mari Sautter
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | | | | | - Fatima Amarir
- Faculty of Sciences Ain Chock, University Hassan II,
Casablanca, Morocco
| | - Kamal El Bissati
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- INH, Rabat, Morocco
| | - Ellen Holfels
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
| | - Richard Penn
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - William Cohen
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
| | | | - Gabrielle Britton
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
| | - Jorge Motta
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
| | - Eduardo Ortega-Barria
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
- GSK Vaccines, Panama City, Panama
| | - Isabel Luz Romero
- Secretaría Nacional de Ciencia, Tecnología
e Innovación (SENACYT), Panama City, Panama
| | - Paul Meier
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
| | - Michael Grigg
- Molecular Parasitology Section, Laboratory of Parasitic
Diseases, National Institutes of Health, NIAID, Bethesda, MD, USA
| | - Jorge Gómez-Marín
- Universidad del Quindío, Armenia, Colombia
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Jagannatha Rao Kosagisharaf
- Instituto de Investigaciones Científicas y Servicios
de Alta Tecnología AIP (INDICASAT-AIP), Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Xavier Sáez Llorens
- Department of Pediatrics Infectious Diseases/Department of
Neonatology, Hospital del Niño Doctor José Renán Esquivel,
Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Osvaldo Reyes
- Universidad de Panamá, Panama City, Panama
- Hospital Santo Tomás, Panama City, Panama
- Sistema Nacional de investigadores de Panamá
(SNI), Panama City, Panama
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| | - Rima McLeod
- Toxoplasmosis Programs and Initiatives in Panamá,
Panama City, Panama
- Institute for Genomics and Systems Biology, The University
of Chicago, Chicago, IL, USA
- Pritzker School of Medicine, The University of Chicago,
Chicago, IL, USA
- Department of Ophthalmology and Visual Sciences, The
University of Chicago, Chicago, IL, USA
- The College, The University of Chicago, Chicago, IL,
USA
- The Global Health Center, The University of Chicago,
Chicago, IL, USA
- Toxoplasmosis Center, The University of Chicago, and
Toxoplasmosis Research Institute, Chicago, IL, USA
- Department of Pediatrics (Infectious Diseases), The
University of Chicago, Chicago, IL, USA
- Jorge Gómez-Marín,
, Jagannatha Rao Kosagisharaf,
, Xavier Sáez Llorens,
, Osvaldo Reyes,
, Rima McLeod,
| |
Collapse
|
14
|
Wang ZM, Li F, Sarigül L, Nachira D, Gonzalez-Rivas D, Badakhshi H, Rückert JC, Ng CSH, Ismail M. A predictive model of lymph node metastasis for thymic epithelial tumours. Eur J Cardiothorac Surg 2022; 62:6566406. [PMID: 35404403 DOI: 10.1093/ejcts/ezac210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Revised: 03/01/2022] [Accepted: 04/06/2022] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES Thymic epithelial tumours (TETs) are relatively rare indolent malignancies in the mediastinum. Lymph node metastasis (LNM) is an important prognostic indicator for TETs; however, the pattern of LNM involved in TETs has yet to be elucidated. METHODS Patients diagnosed with histologically confirmed thymoma (A-B3), thymic carcinomas and thymic neuroendocrine tumours, between 1988 and 2016 were identified from the Surveillance, Epidemiology, and End Results database. Univariable and multivariable logistic regression analyses were applied to identify the predictors for LNM. The predictive nomogram was built from the independent risk factors and measured using the concordance statistic. RESULTS The overall proportion of TETs with LNM was 18.5% (200/1048). The rate of LNM in thymoma, thymic carcinomas and thymic neuroendocrine tumours was 6.8% (42/622), 30.2% (100/331) and 61.1% (58/95), respectively. According to the logistic regression analysis, histology type and T stage were independent factors correlated with LNM. A predictive nomogram model was developed with a concordance statistic of 0.807 (95% confidence interval: 0.773-0.841), which was significantly better than the T stage (P < 0.001) while had limited benefit to the histology type (P = 0.047). The calibration curve for the nomogram comparing the predicted and actual probabilities after bias correction showed good agreement. CONCLUSIONS Nodal involvement was not uncommon in TETs. Main factors related to LNM in TETs were histology type and T stage. The probability of LNM could be well calculated using the predictive model.
Collapse
Affiliation(s)
- Zi-Ming Wang
- Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.,Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Feng Li
- Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.,Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Lara Sarigül
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Dania Nachira
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Diego Gonzalez-Rivas
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.,Department of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit, Coruña University Hospital, Coruña, Spain.,Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
| | - Harun Badakhshi
- Department of Radiation Oncology, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Jens-C Rückert
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Calvin S H Ng
- Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| |
Collapse
|
15
|
Ahmad A, Liu J, Liu Q, Ullah S, Khalid F, Taimur, Ismail M, Mannan A. Tree species composition, growing stock and biomass carbon dynamics of the major timber species in Hindu Kush regions of Pakistan. BRAZ J BIOL 2022; 84:e256425. [PMID: 35293534 DOI: 10.1590/1519-6984.256425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Accepted: 01/19/2022] [Indexed: 11/22/2022] Open
Abstract
Using inventory data, this study evaluates the species composition, growing stock volume (GSV), and biomass carbon (BMC) of the five major timber species in the sub-tropical, and temperate/sub-alpine regions of Pakistan. It was found that the stem density varies between 50 and 221 trees ha -1, with a mean of 142 trees ha-1 (13.68 million trees for entire forest area). Among the species, Pinus wallichiana showed a high species composition (27.80%) followed by Picea smithiana (24.64%). The GSV was found in the range of 67.81 to 425.94 m3 ha-1, with a total GSV value of 20.68 million m3 for the entire region. Similarly, The BMC ranged from 27.04 to 169.86 Mg ha-1, with a mean BMC value of 86.80 Mg ha-1. The total amount of stored carbon was found at 8.69 million tons for a total of 95842 ha of commercially managed forest. Furthermore, the correlation analysis between the basal area (BA) and GSV and BMC showed that BA is the best predictor of GSV and BMC. The findings provide insights to the policy makers and forest managers regarding the sustainable commercial forest management as well as forest carbon management in the recent global carbon management for climate change mitigation.
Collapse
Affiliation(s)
- A Ahmad
- Northwest A&F University, College of Natural Resources and Environment, Yangling, Shaanxi, China.,Beijing Forestry University, Department of Forest Sciences, Beijing, China.,Shaheed Benazir Bhutto University, Department of Forestry, Sheringal Dir Upper, Pakistan.,Institute of Space Technology, National Center of GIS and Space Application - NCGSA, GIS and Space Applications in Geosciences Lab - GSAG-L, Islamabad, Pakistan
| | - J Liu
- Northwest A&F University, College of Natural Resources and Environment, Yangling, Shaanxi, China
| | - Q Liu
- Beijing Forestry University, Department of Forest Sciences, Beijing, China
| | - S Ullah
- Shaheed Benazir Bhutto University, Department of Forestry, Sheringal Dir Upper, Pakistan.,Institute of Space Technology, National Center of GIS and Space Application - NCGSA, GIS and Space Applications in Geosciences Lab - GSAG-L, Islamabad, Pakistan
| | - F Khalid
- Shaheed Benazir Bhutto University, Department of Forestry, Sheringal Dir Upper, Pakistan.,Institute of Space Technology, National Center of GIS and Space Application - NCGSA, GIS and Space Applications in Geosciences Lab - GSAG-L, Islamabad, Pakistan
| | - Taimur
- Khyber Pakhtunkhwa Forest Department, Khyber Pakhtunkhwa, Pakistan
| | - M Ismail
- Khyber Pakhtunkhwa Forest Department, Khyber Pakhtunkhwa, Pakistan
| | - A Mannan
- Karakoram International University, Department of Forestry, Gilgit, Pakistan
| |
Collapse
|
16
|
Nachira D, Congedo MT, Tabacco D, Sassorossi C, Calabrese G, Ismail M, Vita ML, Petracca-Ciavarella L, Margaritora S, Meacci E. Surgical Effectiveness of Uniportal-VATS Lobectomy Compared to Open Surgery in Early-Stage Lung Cancer. Front Surg 2022; 9:840070. [PMID: 35310438 PMCID: PMC8931028 DOI: 10.3389/fsurg.2022.840070] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Accepted: 01/31/2022] [Indexed: 12/25/2022] Open
Abstract
BackgroundAlthough the feasibility and safety of Uniportal-Video-Assisted thoracic surgery (U-VATS) has been proven, its surgical effectiveness is still debated. The aim of this study is to assess the equivalence of the U-VATS approach compared with an open technique in terms of surgical (nodal-upstaging, complications, and post-operative results) and short-term survival outcomes.MethodsThe clinical data of patients undergoing lobectomy for NSCLC at our center, from January 2014 to December 2019, were analyzed retrospectively. All patients undergoing open or U-VATS lobectomy with lymphadenectomy for early-stage lung cancer (cT1-T3N0, stages IA-IIB) were included in the study. Only 230 patients satisfied the inclusion criteria. Group bias was reduced through 1:1 propensity score matching, which resulted in 46 patients in each group (open surgery and U-VATS).ResultsThe intra- and post-operative mortality were null in both groups. There was no difference in the post-operative complications (p: 1.00) between U-VATS and open lobectomy. There was also no recorded difference in the pathological nodal up-staging [11 (23.9%) after thoracotomy vs. 8 (17.4%) after U-VATS, p: 0.440). The chest tube duration was longer in the open group (p: 0.025), with a higher post-operative pain (p: 0.001). Additionally, the 3-year overall survival (OS) was 78% after U-VATS lobectomy vs. 74% after open lobectomy (p: 0.204), while 3-year disease-specific survival (DSS) was 97 vs. 89% (p: 0.371), respectively. The 3-year disease-free survival (DFS) was 62% in the U-VATS group and 66% in the thoracotomy group, respectively (p: 0.917).ConclusionsUniportal-VATS lobectomy for the treatment of early-stage lung cancer seems to be a safe and effective technique with similar surgical and short-term survival outcomes as open surgery, but with lower post-operative pain and shorter in-hospital stay.
Collapse
Affiliation(s)
- Dania Nachira
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
- *Correspondence: Dania Nachira
| | - Maria Teresa Congedo
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Diomira Tabacco
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Carolina Sassorossi
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Giuseppe Calabrese
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Maria Letizia Vita
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Leonardo Petracca-Ciavarella
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Stefano Margaritora
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
| | - Elisa Meacci
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario “A. Gemelli,” Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
- Elisa Meacci
| |
Collapse
|
17
|
O’Connell LV, Hayes C, Ismail M, O’Riordain D, Hafeez A. Attitudes and access of Irish general surgery trainees to robotic surgical training. Surg Open Sci 2022; 9:24-27. [PMID: 35541566 PMCID: PMC9079091 DOI: 10.1016/j.sopen.2022.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 03/07/2022] [Accepted: 03/24/2022] [Indexed: 12/02/2022] Open
Abstract
Background Although the use of robotic-assisted surgery is now mainstream for procedures such as robotic prostatectomy and hysterectomy, its role in general surgery is less well established. Access to training in robotics for general surgery trainees in the Republic of Ireland is variable. Further, there are no data on specific attitudes of Irish trainees toward the role of robotics. We aimed to establish attitudes of Irish general surgery trainees toward the perceived utility of robotic surgery as well as access and satisfaction with training. Methods A survey was disseminated to trainees in the Republic of Ireland enrolled in a General Surgery training scheme via email and social media. Data collected included stage of training, intended subspecialty, interest in developing robotic skills, previous exposure to robotic surgery, satisfaction with current access to robotic training, and opinion on formally incorporating training in robotics into the general surgery curriculum. Results The response rate was 53.8%. Of these, 83% reported interest in training in robotics and 66% anticipated using the technology regularly in consultant practice. Previous exposure to robotic-assisted surgery was significantly predictive of interest in developing the skillset (P = .014). More than 71% of trainees reported that they were not satisfied with access to robotic training. Of those satisfied with access, 40% felt there was a role for incorporating robotic training into the curriculum compared to 68% of those dissatisfied. Conclusion Irish general surgery trainees perceive robotic-assisted surgery to be highly relevant to their future practice. There is an unmet need to provide additional training in the skillset. Irish general surgery trainees perceive robotic surgery (RS) to be highly relevant to their future practice. Access to training in RS is limited, and the majority of trainees desire more access to RS training. Most trainees feel that there is a role for incorporating RS training into the curriculum.
Collapse
|
18
|
Jubran B, Ismail M, Stein M, Little DH, Hansen B, Gulamhusein A, Hirschfield G. A210 HEPATOLITHIASIS IS A FREQUENT AND PROGNOSTIC FINDING IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859231 DOI: 10.1093/jcag/gwab049.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Aims Intrahepatic biliary stones (hepatolithiasis) are not well characterised in patients with primary sclerosing cholangitis (PSC). Methods Chart reviews were conducted on 302 patients with a histologic or radiographic diagnosis of PSC followed at the Toronto Centre for Liver Disease. Radiographic data were collected for patients between the years 2008–2018. Depending on frequency of testing, magnetic resonance imaging (MRI) and ultrasound (US) data was reviewed every 3–5 years. We assessed factors associated with hepatolithiasis based on sex, race, age and phenotype of PSC and inflammatory bowel disease (IBD). Qualitative radiographic findings on image report review, episodes of cholangitis, endoscopic retrograde cholangiopancreatography (ERCP) and occurrence of cholangiocarcinoma (CCA), death and transplant were documented. Data are reported with median and IQR and analysed using χ 2 and Mann-Whitney U tests. Results 302 patients were reviewed. The median time to follow-up, defined as from date of diagnosis to last clinic visit or to transplantation date, was 98 months (IQR = 87). The mean age at diagnosis was 38 (SD = 15.1) years; 54% of patients were male. A total of 224 patients had IBD (74%). Of the 302 patients, 80 patients (26%) had evidence of hepatolithiasis on US or MRI. Patients with hepatolithiasis were more likely to be younger (37.4 vs 39.1, p = 0.025), male (65% vs. 50%, p = 0.021), and have large duct disease (99% vs. 88%, p = 0.004). Imaging report review revealed patients with hepatolithiasis were more likely to have intrahepatic biliary thickening (76% vs. 45%, p < 0.001), extrahepatic biliary thickening (69% vs. 50%, p = 0.003), focal biliary dilation (96% vs. 78%, p < 0.001) and disease characterised by more reported strictures on qualitative imaging report review (89% vs 69%, p < 0.001). Concomitant presence of cholelithiasis was greater in the hepatolithiasis vs. the non-hepatolithiasis group (45% vs. 19%, p < 0.001). There was no significant difference in the prevalence of hepatic or portal venous thrombosis in both groups. Patients with hepatolithiasis more likely have experienced acute ascending cholangitis (50% vs. 20%, p < 0.001) and need for ERCP (50% vs. 35%, p = 0.020). CCA was numerically higher in the hepatolithiasis group (8.75% vs. 4%, p = 0.1). Patients with hepatolithiasis received transplant more frequently (26.3% vs 12.2%, p < 0.001) with no significant difference in mortality. Conclusions Hepatolithiasis is common in PSC and associated with an increased clinical and radiologic disease burden. ![]()
Funding Agencies None
Collapse
Affiliation(s)
- B Jubran
- Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada
| | - M Ismail
- Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada
| | - M Stein
- Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada
| | - D H Little
- Gastroenterology, University of Toronto, Toronto, ON, Canada
| | - B Hansen
- Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada
| | - A Gulamhusein
- Gastroenterology, University of Toronto, Toronto, ON, Canada
| | - G Hirschfield
- Toronto Centre for Liver Disease Francis Family Liver Clinic, Toronto, ON, Canada
| |
Collapse
|
19
|
St-Arnaud R, Pellicelli M, Ismail M, Arabian A, Jafarov T, Zhou CJ. NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH. Int J Mol Sci 2022; 23:ijms23020940. [PMID: 35055125 PMCID: PMC8780913 DOI: 10.3390/ijms23020940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Revised: 01/11/2022] [Accepted: 01/13/2022] [Indexed: 11/28/2022] Open
Abstract
PTH induces phosphorylation of the transcriptional coregulator NACA on serine 99 through Gαs and PKA. This leads to nuclear translocation of NACA and expression of the target gene Lrp6, encoding a coreceptor of the PTH receptor (PTH1R) necessary for full anabolic response to intermittent PTH (iPTH) treatment. We hypothesized that maintaining enough functional PTH1R/LRP6 coreceptor complexes at the plasma membrane through NACA-dependent Lrp6 transcription is important to ensure maximal response to iPTH. To test this model, we generated compound heterozygous mice in which one allele each of Naca and Lrp6 is inactivated in osteoblasts and osteocytes, using a knock-in strain with a Naca99 Ser-to-Ala mutation and an Lrp6 floxed strain (test genotype: Naca99S/A; Lrp6+/fl;OCN-Cre). Four-month-old females were injected with vehicle or 100 μg/kg PTH(1-34) once daily, 5 days a week for 4 weeks. Control mice showed significant increases in vertebral trabecular bone mass and biomechanical properties that were abolished in compound heterozygotes. Lrp6 expression was reduced in compound heterozygotes vs. controls. The iPTH treatment increased Alpl and Col1a1 mRNA levels in the control but not in the test group. These results confirm that NACA and LRP6 form part of a common genetic pathway that is necessary for the full anabolic effect of iPTH.
Collapse
Affiliation(s)
- René St-Arnaud
- Research Centre, Shriners Hospital for Children—Canada, Montreal, QC H4A 0A9, Canada; (M.P.); (M.I.); (A.A.); (T.J.)
- Department of Surgery, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 1A4, Canada
- Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 0C7, Canada
- Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 1A1, Canada
- Correspondence: ; Tel.: +1-514-282-7155; Fax: +1-514-842-5581
| | - Martin Pellicelli
- Research Centre, Shriners Hospital for Children—Canada, Montreal, QC H4A 0A9, Canada; (M.P.); (M.I.); (A.A.); (T.J.)
| | - Mahmoud Ismail
- Research Centre, Shriners Hospital for Children—Canada, Montreal, QC H4A 0A9, Canada; (M.P.); (M.I.); (A.A.); (T.J.)
| | - Alice Arabian
- Research Centre, Shriners Hospital for Children—Canada, Montreal, QC H4A 0A9, Canada; (M.P.); (M.I.); (A.A.); (T.J.)
| | - Toghrul Jafarov
- Research Centre, Shriners Hospital for Children—Canada, Montreal, QC H4A 0A9, Canada; (M.P.); (M.I.); (A.A.); (T.J.)
| | - Chengji J. Zhou
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA 95817, USA;
- Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children—Northern California, Sacramento, CA 95817, USA
| |
Collapse
|
20
|
Ismail M, La S, Tavella R, Beltrame J. Relationship Between Corrected TIMI Frame Count (cTFC) and Coronary Haemodynamic Parameters in Patients With Angina and Non-Obstructive Coronary Arteries (ANOCA). Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
21
|
Khalaf N, Abdel-Latif E, Ismail M, Metwally H. Utilisation of bis-chloroacetamide derivative in the synthesis of new biologically active sulfide compounds. S Afr j chem 2022. [DOI: 10.17159/0379-4350/2021/v76a14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
4-Aminobenzohydrazide (1) undergoes chloroacetylation twice, at the primary amine and hydrazide-NH2 functional groups. The conforming bis-chloroacetamide derivative 3 was reacted with different sulfur reagents (namely, 2-mercaptobenzothiazole, 6-amino-2-mercaptopyrimidin-4-ol, and 2-mercapto-4,6-dimethyl-nicotinonitrile) to give new bis-sulfide compounds 5, 7 and 9, respectively. The newly synthesised bis-chloroacetamide and corresponding sulfides were screened for anti-microbial and antioxidant potential. The sulfide derivative 7 exhibited the most potent activity against Staphylococcus aureus and Pseudomonas aeruginosa. It shows inhibition activities of 83.4% and 78.8%, respectively. Moreover, the sulfide derivative 7 showed the highest antioxidant activity with an inhibition ratio of 85.9%, which is close to L-ascorbic acid.
Collapse
|
22
|
Ijaz MU, Majeed SA, Asharaf A, Ali T, Al-Ghanim KA, Asad F, Zafar S, Ismail M, Samad A, Ahmed Z, Al-Misned F, Riaz MN, Mahboob S. Toxicological effects of thimerosal on rat kidney: a histological and biochemical study. BRAZ J BIOL 2021; 83:e242942. [PMID: 34468508 DOI: 10.1590/1519-6984.242942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2020] [Accepted: 02/17/2021] [Indexed: 11/21/2022] Open
Abstract
Thimerosal is an organomercurial compound, which is used in the preparation of intramuscular immunoglobulin, antivenoms, tattoo inks, skin test antigens, nasal products, ophthalmic drops, and vaccines as a preservative. In most of animal species and humans, the kidney is one of the main sites for mercurial compounds deposition and target organs for toxicity. So, the current research was intended to assess the thimerosal induced nephrotoxicity in male rats. Twenty-four adult male albino rats were categorized into four groups. The first group was a control group. Rats of Group-II, Group-III, and Group-IV were administered with 0.5µg/kg, 10µg/kg, and 50µg/kg of thimerosal once a day, respectively. Thimerosal administration significantly decreased the activities of catalase (CAT), superoxide dismutase (SOD), peroxidase (POD), glutathione reductase (GR), glutathione (GSH), and protein content while increased the thiobarbituric acid reactive substances (TBARS) and hydrogen peroxide (H2O2) levels dose-dependently. Blood urea nitrogen (BUN), creatinine, urobilinogen, urinary proteins, kidney injury molecule-1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL) levels were substantially increased. In contrast, urinary albumin and creatinine clearance was reduced dose-dependently in thimerosal treated groups. The results demonstrated that thimerosal significantly increased the inflammation indicators including nuclear factor kappaB (NF-κB), tumor necrosis factor-α (TNF-α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6) levels and cyclooxygenase-2 (COX-2) activities, DNA and histopathological damages dose-dependently. So, the present findings ascertained that thimerosal exerted nephrotoxicity in male albino rats.
Collapse
Affiliation(s)
- M U Ijaz
- University of Agriculture, Department of Zoology, Wildlife and Fisheries, Faisalabad, Pakistan
| | - S A Majeed
- University of Agriculture, Department of Zoology, Wildlife and Fisheries, Faisalabad, Pakistan
| | - A Asharaf
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - T Ali
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - K A Al-Ghanim
- King Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia
| | - F Asad
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - S Zafar
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - M Ismail
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - A Samad
- University of Agriculture, Department of Zoology, Wildlife and Fisheries, Faisalabad, Pakistan
| | - Z Ahmed
- Government College University, Department of Zoology, Faisalabad, Pakistan
| | - F Al-Misned
- King Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia
| | - M N Riaz
- Texas A&M University, AMU, Brazos, Texas, United States of America
| | - S Mahboob
- King Saud University, Department of Zoology, College of Science, Riyadh, Saudi Arabia
| |
Collapse
|
23
|
Gozal D, Ismail M, Brockmann PE. Alternatives to surgery in children with mild OSA. World J Otorhinolaryngol Head Neck Surg 2021; 7:228-235. [PMID: 34430830 PMCID: PMC8356096 DOI: 10.1016/j.wjorl.2021.03.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2021] [Revised: 02/17/2021] [Accepted: 03/18/2021] [Indexed: 12/01/2022] Open
Abstract
Precision medicine requires coordinated and integrated evidence-based combinatorial approaches so that diagnosis and treatment can be tailored to the individual patient. In this context, the treatment approach to mild obstructive sleep apnea (OSA) is fraught with substantial debate as to what is mild OSA, and as to what constitutes appropriate treatment. As such, it is necessary to first establish a proposed consensus of what criteria need to be employed to reach the diagnosis of mild OSA, and then examine the circumstances under which treatment is indicated, and if so, whether and when anti-inflammatory therapy (AIT), rapid maxillary expansion (RME), and/or myofunctional therapy (MFT) may be indicated.
Collapse
Affiliation(s)
- David Gozal
- Department of Child Health and Child Health Research Institute, and MU Women and Children's Hospital, University of Missouri School of Medicine, Columbia, MO, USA
| | - Mahmoud Ismail
- Department of Neurology and Sleep Medicine, University of Missouri School of Medicine, Columbia, MO, USA
| | - Pablo E Brockmann
- Department of Pediatric Cardiology and Pulmonology, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.,Pediatric Sleep Center, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| |
Collapse
|
24
|
Soror T, Kovács G, Wecker S, Ismail M, Badakhshi H. Palliative treatment with high-dose-rate endobronchial interventional radiotherapy (Brachytherapy) for lung cancer patients. Brachytherapy 2021; 20:1269-1275. [PMID: 34429246 DOI: 10.1016/j.brachy.2021.06.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 06/23/2021] [Accepted: 06/23/2021] [Indexed: 10/20/2022]
Abstract
PURPOSE to report on the use of high-dose-rate (HDR) endobronchial interventional radiotherapy (brachytherapy, EBIRT) for palliation of symptoms in patients with lung cancer. PATIENTS AND METHODS retrospective review of lung cancer patients treated with HDR-EBIRT at our institution (1995-2017). Treatment results and treatment related toxicity were recorded. Clinical response was subjectively evaluated within 3 months after treatment. Overall survival (OS) was analyzed. RESULTS 347 patients were identified. The median age was 69 years and the median follow-up time was 13.4 months. Most patients received external beam radiation therapy during the primary treatment. Within 3 months, 87.7% of the patients had complete or major response of their presenting symptoms. OS was 55.2% at 1 year, 18.3% at 2 years. Patients who had complete or major response had a longer median survival than other patients (13 versus 7 months, p = 0.03). Chronic bronchitis was found in 26.8%, while 7.8% of the patients died due to uncontrollable hemoptysis. CONCLUSION HDR-EBIRT is a safe and effective treatment option for the palliative treatment of lung cancer patients. HDR-EBIRT is most suitable as a re-irradiation technique. Further clinical studies are needed to validate its role.
Collapse
Affiliation(s)
- Tamer Soror
- Radiation Oncology Department, University of Lübeck/UKSH-CL, Lübeck, Germany; National Cancer Institute (NCI), Radiation Oncology Department, Cairo University, Egypt.
| | - György Kovács
- Università Cattolica del Sacro Cuore, Gemelli-INTERACTS, Roma, Italy
| | - Sacha Wecker
- Department of Clinical Radiation Oncology, Ernst von Bergmann Medical Center, Academic Teaching Hospital of Humboldt University Berlin (Charité), Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Ernst von Bergmann Medical Center, Academic Teaching Hospital of Humboldt University Berlin (Charité), Germany
| | - Harun Badakhshi
- Department of Clinical Radiation Oncology, Ernst von Bergmann Medical Center, Academic Teaching Hospital of Humboldt University Berlin (Charité), Germany
| |
Collapse
|
25
|
Li F, Li Z, Chen Y, Bauer G, Uluk D, Elsner A, Swierzy M, Ismail M, Meisel A, Rückert JC. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate. Eur J Cardiothorac Surg 2021; 57:478-487. [PMID: 31628812 DOI: 10.1093/ejcts/ezz275] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Revised: 08/31/2019] [Accepted: 09/11/2019] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES This study aimed to compare the outcomes of patients with ocular myasthenia gravis (OMG) who underwent thymectomy before generalization with the outcomes of those who underwent thymectomy after generalization. METHODS We retrospectively reviewed patients who underwent robotic thymectomy for myasthenia gravis between January 2003 and February 2018. Patients who presented with purely ocular symptoms at myasthenia gravis onset were eligible for inclusion. Exclusion criteria were patients who were lost to follow-up and patients who underwent re-thymectomy. Patients with OMG who developed generalization before thymectomy were categorized into gOMG group and those who did not were categorized into OMG group. The primary outcome was complete stable remission according to the Myasthenia Gravis Foundation of America Post-Intervention Status (MGFA-PIS). RESULTS One hundred and sixty-five (66 males and 99 females) out of 596 patients with myasthenia gravis were eligible for inclusion. Of these, there were 73 and 92 patients undergoing thymectomy before and after the generalization of OMG, respectively. After propensity score matching, a data set of 130 patients (65 per group) was formed and evaluating results showed no statistical differences between the 2 groups. The estimated cumulative probabilities of complete stable remission at 5 years were 49.5% [95% confidence interval (CI) 0.345-0.611] in the OMG group and 33.4% (95% CI 0.176-0.462) in the gOMG group (P = 0.0053). Similar results were also found in patients with non-thymomatous subgroup [55 patients per group, OMG vs gOMG, 53.5% (95% CI 0.370-0.656) vs 28.9% (95% CI 0.131-0.419), P = 0.0041]. CONCLUSIONS Thymectomy in OMG before generalization might result in a higher rate of complete stable remission than thymectomy after generalization.
Collapse
Affiliation(s)
- Feng Li
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Zhongmin Li
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Yanli Chen
- Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Gero Bauer
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Deniz Uluk
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Aron Elsner
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Marc Swierzy
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Mahmoud Ismail
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Andreas Meisel
- Department of Neurology, Integrated Center for Myasthenia Gravis, NeuroCure Clinical Research Center, Center for Stroke Research Berlin, Charité - University Medicine Berlin, Berlin, Germany
| | - Jens-C Rückert
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| |
Collapse
|
26
|
Wang ZM, Xu QR, Kaul D, Ismail M, Badakhshi H. Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors. Thorac Cancer 2021; 12:1995-2006. [PMID: 34033229 PMCID: PMC8258363 DOI: 10.1111/1759-7714.14002] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Revised: 04/28/2021] [Accepted: 04/29/2021] [Indexed: 01/25/2023] Open
Abstract
Background Thymic epithelial tumors (TETs) are relatively rare malignant thoracic tumors. Tumor mutation burden (TMB) and immune infiltration play important roles in tumorigenesis. Methods Research data was obtained using the Cancer Genome Atlas (TCGA) database to evaluate the landscape of tumor mutations, related factors, and relationship of prognosis. The CIBERSORT algorithm was used to evaluate immune cell infiltration in TETs and its relationship with TMB. Immune‐related differentially expressed genes (irDEGs) were identified. Hub irDEGs independently related to prognosis were analyzed using univariate and multivariate Cox proportional hazard models. A survival signature was constructed from hub irDEGs. Results A total of 122 patients were included in this study. GTF2I was the most common gene mutation. Higher TMB was significantly associated with the later stage, more advanced pathological type, and older age. The overall survival (OS) of patients in the low‐TMB group was significantly better. There was no significant correlation between TMB levels and PD‐L1 expression. Enrichment analysis showed that DEGs were mainly involved in the P13K–Akt signaling pathway. There were significant differences in macrophage and other types of immune cell infiltration between the high‐ and low‐TMB groups. CCR5, FASLG, and CD79A independently relating to prognosis were screened from 391 irDEGs. The low‐risk group had a significantly better prognosis than the high‐risk group based on the signature, which has a good predictive effect on OS. Conclusions In this study, TETs patients with high TMB had a significantly poor prognosis and an immune‐related gene signature was found to effectively evaluate the long‐term prognosis.
Collapse
Affiliation(s)
- Zi-Ming Wang
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.,Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of Charité - Universitätsmedizin Berlin, Potsdam, Germany
| | - Qi-Rong Xu
- School of Medicine, Zhengzhou University, Zhengzhou, China
| | - David Kaul
- Department of Radiation Oncology, Charité-Universitätsmedizin Humboldt University Berlin, Berlin, Germany
| | - Mahmoud Ismail
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.,Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of Charité - Universitätsmedizin Berlin, Potsdam, Germany
| | - Harun Badakhshi
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.,Department of Radiation Oncology, Klinikum Ernst von Bergmann, Academic Hospital of Charité - Universitätsmedizin Berlin, Potsdam, Germany
| |
Collapse
|
27
|
Mansour H, Elnaghi B, Abd-Alwahab M, Ismail M. Optimum Topology of Power Distribution Networks Using Sunflower Optimizer for Loss Reduction.(Dept.E). MEJ Mansoura Engineering Journal 2021; 46:1-10. [DOI: 10.21608/bfemu.2021.171090] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
28
|
Li R, Veltzke-Schlieker W, Adler A, Ismail M, Badakhshi H, Zorron R. Intragastric Single-Port Surgery: An Innovative and Multipurpose Technique for the Therapy of Upper Digestive Tract Lesions. Surg Innov 2021; 29:56-65. [PMID: 33914655 DOI: 10.1177/15533506211015386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background: Endoscopic treatment can represent a technical challenge for several special situations, such as resecting gastric tumors with larger size or in unfavorable sites and performing endoscopic retrograde cholangiopancreatography (ERCP) after Roux-en-Y gastric bypass (RYGB). This study aims to describe an innovative and multipurpose technique, intragastric single-port surgery (IGS), which can be applied for abovementioned special situations and for assessing its safety, feasibility, and efficacy. Methods: IGS technique was performed through a 2-3 cm skin incision, where the stomach wall is exteriorized and fixed to the skin. The single-port device is inserted and intragastric access is gained for laparoscopic or endoscopic instruments. Three purposes of IGS were performed: (1). gastric intraluminal lesions resection; (2). to perform ERCP after RYGB; and (3). revision of pancreaticogastric anastomosis after pylorus-preserving pancreaticoduodenectomy. Results: IGS was performed successfully in 20 patients. Ten patients underwent gastric intraluminal lesion resection, mostly for gastric gastrointestinal stromal tumors (n = 7, 70%); all pathological specimens were with negative margin, mean operation time was 102.3 ± 43.5 minutes, and mean postoperative hospital stay was 4.6 ± 1.5 days. Nine patients underwent ERCP after RYGB, cleaning of the bile duct was successful in all patients (100%), and mean operation time and mean postoperative hospital stay were 140.6 ± 46.3 minutes and 4.4 ± 2.6 days, respectively. One patient underwent pancreaticogastric anastomosis revision. There were no mortalities in our series. Conclusions: IGS is a safe, feasible, and effective technique for gastric intraluminal lesion resection and for performing ERCP after RYGB, while it has the potential for other future applications.
Collapse
Affiliation(s)
- Renjie Li
- Center for Bariatric and Metabolic Surgery, 14959Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
- Department of Clinical Radiation Oncology, 14959Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Wilfried Veltzke-Schlieker
- Division Interdisciplinary Endoscopy, Department for Hepatology and Gastroenterology, Campus Virchow Klinikum, 72217Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Andreas Adler
- Division Interdisciplinary Endoscopy, Department for Hepatology and Gastroenterology, Campus Virchow Klinikum, 72217Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, 14959Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Harun Badakhshi
- Department of Clinical Radiation Oncology, 14959Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Ricardo Zorron
- Center for Bariatric and Metabolic Surgery, 14959Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| |
Collapse
|
29
|
Li R, Veltzke-Schlieker W, Adler A, Specht M, Eskander W, Ismail M, Badakhshi H, Galvao MP, Zorron R. Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m 2) Patients, and Contraindication to Abdominal Surgery. Obes Surg 2021; 31:3400-3409. [PMID: 33905069 DOI: 10.1007/s11695-021-05446-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 04/18/2021] [Accepted: 04/21/2021] [Indexed: 12/17/2022]
Abstract
BACKGROUND For high-risk classified patients, patients with superobesity and in cases of contraindication to abdominal surgery, traditional bariatric surgery might lead to potential morbidity and mortality. Endoscopic sleeve gastroplasty (ESG) is a novel and effective bariatric therapy for morbidly obese patients. Our research group initially evaluated the safety, feasibility, and efficacy of ESG for high-risk, high body mass index (BMI) patients, and patients contraindicated to abdominal surgeries. METHODS Eligible patients characterized as high-risk for bariatric surgery due to high-BMI, severe comorbidities, or impenetrable abdomen were prospectively documented. ESG was performed by using Overstich® (Apollo Endosurgery, Austin, TX, USA). Primary outcomes included technical success, post-procedure adverse events and mortality, and the change of weight and BMI. RESULTS ESG was successfully performed for all patients (N = 24, mean age was 55.6 (± 9.2) years old, 75% male). Baseline weight and BMI were 157.9 (± 49.1) kg and 49.9 (± 14.4) kg/m2. According to Edmonton Obesity Staging System (EOSS), 8 (33.3%), 14 (58.3%), and 2 (8.3%) patients were respectively classified as EOSS 2, 3, and 4. Mean operation time was 114.7 (± 26.0) min, without intraoperative complication. Weight loss, BMI reduction, %total weight loss (%TWL), and %excess weight loss (%EWL) were 17.5 (± 14.6) kg, 5.6 (± 4.6) kg/m2, 12.2% (± 8.9%), and 29.1% (± 17.9%) at post-ESG 12-month, respectively. One (4.2%) moderate post-procedure adverse event (gastric mucosal bleeding) was observed. CONCLUSIONS ESG can be used as a safe, feasible, and effective option for the therapy of patients with superobesity, high-risk patients, and patients contraindicated to abdominal surgery. Graphical Abstract.
Collapse
Affiliation(s)
- Renjie Li
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467, Potsdam, Germany
| | - Wilfried Veltzke-Schlieker
- Division Interdisciplinary Endoscopy, Department for Hepatology and Gastroenterology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Andreas Adler
- Division Interdisciplinary Endoscopy, Department for Hepatology and Gastroenterology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - Maximilian Specht
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467, Potsdam, Germany
| | - Wael Eskander
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467, Potsdam, Germany
| | - Mahmoud Ismail
- Department for Thoracic Surgery, Klinikum Ernst von Bergmann, Potsdam, Germany
| | - Harun Badakhshi
- Clinic for Radiooncology and Radiotherapy, Klinikum Ernst von Bergmann, Potsdam, Germany
| | | | - Ricardo Zorron
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467, Potsdam, Germany.
| |
Collapse
|
30
|
Wang ZM, Swierzy M, Balke D, Nachira D, González-Rivas D, Badakhshi H, Ismail M. Dynamic nomogram for long-term survival in patients with non-small cell lung cancer after pneumonectomy. J Thorac Dis 2021; 13:2276-2287. [PMID: 34012578 PMCID: PMC8107554 DOI: 10.21037/jtd-20-3203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Background The study aims to identify prognostic factors of overall survival (OS) in patients who had pneumonectomy, in order to develop a practical dynamic nomogram model. Methods A total of 2,255 patients with non-small cell lung cancer (NSCLC) who underwent pneumonectomy were identified from 2010-2015 in the Surveillance, Epidemiology, and End Results (SEER) database. The cohort was divided into a training (2011-2015) and a validation [2010] cohort. A nomogram and a risk classification system were constructed from the independent survival factors in multivariable analysis. The predictive accuracy of the nomogram was measured through internal and external validation. Results Independent prognostic factors associated with OS were gender, age, pathology, tumor size, N stage, chemotherapy, and radiotherapy. The C-index of the nomogram for OS was 0.675 (95% CI: 0.655-0.694). Similarly, the AUC of the model was 0.733, 0.709, and 0.701 for the 1-, 3-, and 5-year OS, respectively. The calibration curves for survival demonstrated good agreement. Significant statistical differences were found in the OS of patients within different risk groups. An online calculation tool was established for clinical use. Conclusions This novel nomogram was able to provide a reliable prognosis for survival in patients with NSCLC undergoing pneumonectomy.
Collapse
Affiliation(s)
- Zi-Ming Wang
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Marc Swierzy
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Dany Balke
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Dania Nachira
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario "A. Gemelli", Rome, Italy
| | - Diego González-Rivas
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.,Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.,Department of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit, Coruña University Hospital, Coruña, Spain
| | - Harun Badakhshi
- Department of Radiation Oncology, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| |
Collapse
|
31
|
Ismail M, Ralls FM, Brown LK. A Life-threatening Complication of Multiple System Atrophy. Chest 2021; 159:e163-e166. [PMID: 33678286 DOI: 10.1016/j.chest.2020.09.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Revised: 08/30/2020] [Accepted: 09/29/2020] [Indexed: 10/22/2022] Open
Abstract
CASE PRESENTATION A 50-year-old woman was initially seen in 2016 for sleep disorders consultation, referred by Neurology because of progressive cerebellar ataxia syndrome with possible autonomic involvement and sleep-disordered breathing described as having stridorous sounds during her sleep. She had initially presented to Neurology because of issues with balance, and she had frequent falls at home. In 2016, her speech was clear, and she was able to ambulate steadily with a cane. She underwent a diagnostic polysomnogram that did not demonstrate clinically significant sleep apnea. However, the study demonstrated rapid eye movement (REM) sleep without atonia in 62% of REM epochs (normal, up to 27%) and a soft inspiratory stridor during non-REM and REM sleep. The patient was lost to follow-up until she presented to us for reevaluation 3 years later. In the interim, she had been diagnosed with multiple system atrophy-cerebellar type (MSA-C) at another health-care institution.
Collapse
Affiliation(s)
- Mahmoud Ismail
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM
| | | | - Lee K Brown
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM; Sleep Disorders Centers, University of New Mexico Health System, Albuquerque, NM; Department of Electrical and Computer Engineering, University of New Mexico School of Engineering, Albuquerque, NM
| |
Collapse
|
32
|
Badakhshi H, Wang ZM, Li RJ, Ismail M, Kaul D. Survival and Prognostic Nomogram for Primary Gastrointestinal Melanoma (PGIM): A Population-based Study. Anticancer Res 2021; 41:967-974. [PMID: 33517303 DOI: 10.21873/anticanres.14850] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 01/13/2021] [Accepted: 01/18/2021] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Primary gastrointestinal mucosal melanoma (PGIM) is an aggressive and rare disease, commonly with poor prognosis. We aimed to determine the clinical risk and prognosis of this rare entity. PATIENTS AND METHODS Patients (n=962) with PGIM documented in the Surveillance, Epidemiology, and End Results database between 1975-2016 were included. Prognostic factors on overall survival (OS) and cancer-specific survival (CSS) were identified. A nomogram was constructed to predict the OS of PGIM patients. RESULTS Primary site, summary stage, and therapeutic method were all independent predictors of OS and CSS, and age was the only factor significantly associated with OS. Independent prognostic factors of OS were selected to develop a predictive nomogram. The Harrell's C-index of the nomogram was 0.712, the area under the curve (AUC) was 0.746, 0.758, 0.810 for the 1-, 3-, and 5-year OS, respectively, and calibration plots were in good agreement. CONCLUSION Several prognostic factors of PGIM were demonstrated and a practical nomogram model was created in this study.
Collapse
Affiliation(s)
- Harun Badakhshi
- Department of Radiation Oncology, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany;
| | - Zi-Ming Wang
- Department of Radiation Oncology, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.,Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Ren-Jie Li
- Department of Radiation Oncology, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.,Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - David Kaul
- Department of Radiation Oncology, Charité-Universitätsmedizin Humboldt University Berlin, Berlin, Germany
| |
Collapse
|
33
|
Rückert JC, Zhang H, Li F, Uluk D, Ismail M, Meisel A. Complete thymectomy for myasthenia gravis. J Vis Surg 2021. [DOI: 10.21037/jovs.2020.03.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
34
|
Najah A, Teo FY, Chow MF, Huang YF, Latif SD, Abdullah S, Ismail M, El-Shafie A. Surface water quality status and prediction during movement control operation order under COVID-19 pandemic: Case studies in Malaysia. Int J Environ Sci Technol (Tehran) 2021; 18:1009-1018. [PMID: 33558809 PMCID: PMC7857098 DOI: 10.1007/s13762-021-03139-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Revised: 12/09/2020] [Accepted: 01/06/2021] [Indexed: 05/06/2023]
Abstract
Global concerns have been observed due to the outbreak and lockdown causal-based COVID-19, and hence, a global pandemic was announced by the World Health Organization (WHO) in January 2020. The Movement Control Order (MCO) in Malaysia acts to moderate the spread of COVID-19 through the enacted measures. Furthermore, massive industrial, agricultural activities and human encroachment were significantly reduced following the MCO guidelines. In this study, first, a reconnaissance survey was carried out on the effects of MCO on the health conditions of two urban rivers (i.e., Rivers of Klang and Penang) in Malaysia. Secondly, the effect of MCO lockdown on the water quality index (WQI) of a lake (Putrajaya Lake) in Malaysia is considered in this study. Finally, four machine learning algorithms have been investigated to predict WQI and the class in Putrajaya Lake. The main observations based on the analysis showed that noticeable enhancements of varying degrees in the WQI had occurred in the two investigated rivers. With regard to Putrajaya Lake, there is a significant increase in the WQI Class I, from 24% in February 2020 to 94% during the MCO month of March 2020. For WQI prediction, Multi-layer Perceptron (MLP) outperformed other models in predicting the changes in the index with a high level of accuracy. For sensitivity analysis results, it is shown that NH3-N and COD play vital rule and contributing significantly to predicting the class of WQI, followed by BOD, while the remaining three parameters (i.e. pH, DO, and TSS) exhibit a low level of importance.
Collapse
Affiliation(s)
- A. Najah
- Institute of Energy Infrastructure (IEI), Universiti Tenaga Nasional (UNITEN), 43000 Kajang, Selangor Darul Ehsan Malaysia
| | - F. Y. Teo
- Faculty of Science and Engineering, University of Nottingham Malaysia, 43500 Semenyih, Selangor Malaysia
| | - M. F. Chow
- Institute of Sustainable Energy (ISE), Universiti Tenaga Nasional (UNITEN), 43000 Kajang, Selangor Malaysia
| | - Y. F. Huang
- Department of Civil Engineering, Lee Kong Chian Faculty of Engineering and Science, Universiti Tunku Abdul Rahman, Kajang, Selangor Malaysia
| | - S. D. Latif
- Department of Civil Engineering, College of Engineering, Universiti Tenaga Nasional (UNITEN), 43000 Kajang, Selangor Malaysia
| | - S. Abdullah
- Air Quality and Environment Research Group, Faculty of Ocean Engineering Technology and Informatics, Universiti Malaysia Terengganu, 21030 Kuala Nerus, Terengganu Malaysia
| | - M. Ismail
- Faculty of Science and Marine Environment, Universiti Malaysia Terengganu, 21030 Kuala Nerus, Terengganu Malaysia
- Institute of Tropical Biodiversity and Sustainable Development, Universiti Malaysia Terengganu, 21030 Kuala Nerus, Malaysia
| | - A. El-Shafie
- Department of Civil Engineering, Faculty of Engineering, University of Malaya (UM), 50603 Kuala Lumpur, Malaysia
- National Water and Energy Center (NWC), United Arab Emirates University, P.O. Box. 15551, Al Ain, United Arab Emirates
| |
Collapse
|
35
|
Ismail M, Ebrahim Z, Abdullaziz I, Metwally M. Acute phase response and some hematobiochemical alterations in some selected canine disease. AJVS 2021. [DOI: 10.5455/ajvs.89014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
36
|
Wang ZM, Li F, Liu XY, Nachira D, Badakhshi H, Rückert JC, Ismail M. Effect of Lymph Node Dissection on the Prognosis of Thymic Carcinomas and Thymic Neuroendocrine Tumors. Semin Thorac Cardiovasc Surg 2020; 33:568-578. [PMID: 33181313 DOI: 10.1053/j.semtcvs.2020.11.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2020] [Accepted: 11/05/2020] [Indexed: 11/11/2022]
Abstract
We aimed to analyze the effect of lymph node dissection (LND) and accurate lymph node (LN) status on the survival and prognosis of patients with thymic carcinomas (TCs) and thymic neuroendocrine tumors (TNETs) undergoing surgical treatment. The Surveillance, Epidemiology, and End Results database was queried for patients who underwent surgical resection for TCs and TNETs during 1998-2016. LN status were defined as no LND (LND-), pathologically negative with LND (N0), and LN metastasis positive (N+). We investigated outcomes of LN status together with other clinicopathological features for overall survival (OS). Subgroup analyses were performed between LND-, N0, and N+ cohorts using propensity score matching, to analyze the significance of LND in prognosis. A total of 812 patients were enrolled, including 623 with TCs and 189 with TNETs. The proportion of LN metastasis positive in TNETs was 58.8% which was significantly higher than that in TCs (30%) (P < 0.001). In multivariable Cox analysis of OS, patients with LND- had a significantly worse prognosis than those with N0 (P = 0.018); there was no difference between N+ and LND- (P = 0.560). After propensity score matching, patients with N0 still had better survival than those with LND- and N+ in subgroup univariable and multivariable analyses of OS; however, the survival of patients with LND- and N+ was not significantly different in multivariable analysis. It was demonstrated that LND in TCs and TNETs can clarify the status of LN metastasis, to more accurately evaluate patients' long-term prognosis.
Collapse
Affiliation(s)
- Zi-Ming Wang
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Feng Li
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Xin-Ying Liu
- Department of Pathology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China
| | - Dania Nachira
- Department of General Thoracic Surgery, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Harun Badakhshi
- Department of Radiation Oncology, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Jens-C Rückert
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany.
| |
Collapse
|
37
|
Ismail M, Cope A, Weng C, Mara K, Burnett T, Khan Z. The Effect of Abuse History on Preoperative and Postoperative Pain Symptoms in Women Undergoing Surgical Treatment of Endometriosis. J Minim Invasive Gynecol 2020. [DOI: 10.1016/j.jmig.2020.08.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
38
|
Sheta A, Ismail M, Tag El-Din AEM, El-Shahed A. Comparison between Femtosecond Assisted LASIK and Small Incision Lenticule Extraction (SMILE) for Correction of Myopia. Al-Azhar International Medical Journal 2020; 0:0-0. [DOI: 10.21608/aimj.2020.28754.1206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
39
|
Li R, Ismail M, Badakhshi H, Zorron R. Intragastric single-port surgery (IGS) for gastric endophytic gastrointestinal stromal tumor (GIST): A novel surgical treatment. Surg Oncol 2020; 35:12-13. [PMID: 32771957 DOI: 10.1016/j.suronc.2020.06.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Revised: 06/11/2020] [Accepted: 06/14/2020] [Indexed: 11/17/2022]
Abstract
BACKGROUND Intragastric surgery with a single incision has been performed for several diseases, such as gastric tumors[1] and pancreatic pseudocyst[2], safety, feasibility and potential benefits of which have been reported in previous relevant studies[3]. METHODS The video shows a 65-year-old man with upper gastrointestinal hemorrhage, preoperative abdominal CT scan and endoscopy suggested an endophytic tumor located in gastric corpus, suggesting gastrointestinal stromal tumor (GIST). Intragastric single-port surgery (IGS) was indicated. RESULTS Under general anesthesia, patient was placed in supine position. Surgeons stood on the right side of the patient. After a 2.5cm transverse incision was made on left upper abdominal wall, gastric anterior wall was exteriorized and fixed to the skin incision. Single-port device was inserted inside the stomach after anterior gastric wall was opened. Next, laparoscope was introduced into gastric cavity and identified the location of tumor. Full thickness resection of the tumor was performed by using linear stapler, then stapler line was embedded with continuous sutures. Finally, after specimen and single-port device removal, the stomach incision was closed extracorporeally. The operation time was 112 minutes. Final pathology confirmed GIST (4.5cm) with negative margins and patient discharged after 4 days, without postoperative complications. In 1-year follow-up time, without recurrence or death. CONCLUSION IGS is safe and effective for gastric endophytic GIST resection, which not only preserves all advantages of conventional laparoscopic operation, but also includes other benefits like obviating the need of abdominal cavity exploration, potential reduction of risk of neoplasm seeding, and offering good postoperative cosmetic result.
Collapse
Affiliation(s)
- Renjie Li
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Potsdam, Germany
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann, Potsdam, Germany
| | - Harun Badakhshi
- Department of Clinical Radiation Oncology, Klinikum Ernst von Bergmann, Potsdam, Germany
| | - Ricardo Zorron
- Center for Bariatric and Metabolic Surgery, Klinikum Ernst von Bergmann, Potsdam, Germany.
| |
Collapse
|
40
|
Batiha GES, Alqahtani A, Ojo OA, Shaheen HM, Wasef L, Elzeiny M, Ismail M, Shalaby M, Murata T, Zaragoza-Bastida A, Rivero-Perez N, Magdy Beshbishy A, Kasozi KI, Jeandet P, Hetta HF. Biological Properties, Bioactive Constituents, and Pharmacokinetics of Some Capsicum spp. and Capsaicinoids. Int J Mol Sci 2020; 21:ijms21155179. [PMID: 32707790 PMCID: PMC7432674 DOI: 10.3390/ijms21155179] [Citation(s) in RCA: 66] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 07/16/2020] [Accepted: 07/21/2020] [Indexed: 02/07/2023] Open
Abstract
Pepper originated from the Capsicum genus, which is recognized as one of the most predominant and globally distributed genera of the Solanaceae family. It is a diverse genus, consisting of more than 31 different species including five domesticated species, Capsicum baccatum, C. annuum, C. pubescen, C. frutescens, and C. chinense. Pepper is the most widely used spice in the world and is highly valued due to its pungency and unique flavor. Pepper is a good source of provitamin A; vitamins E and C; carotenoids; and phenolic compounds such as capsaicinoids, luteolin, and quercetin. All of these compounds are associated with their antioxidant as well as other biological activities. Interestingly, Capsicum fruits have been used as food additives in the treatment of toothache, parasitic infections, coughs, wound healing, sore throat, and rheumatism. Moreover, it possesses antimicrobial, antiseptic, anticancer, counterirritant, appetite stimulator, antioxidant, and immunomodulator activities. Capsaicin and Capsicum creams are accessible in numerous ways and have been utilized in HIV-linked neuropathy and intractable pain.
Collapse
Affiliation(s)
- Gaber El-Saber Batiha
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
- Correspondence: (G.E.-S.B.); (A.M.B.); (H.F.H.)
| | - Ali Alqahtani
- Department of Pharmacology, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia;
| | | | - Hazem M. Shaheen
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
| | - Lamiaa Wasef
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
| | - Mahmoud Elzeiny
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
| | - Mahmoud Ismail
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
| | - Mahmoud Shalaby
- Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt; (H.M.S.); (L.W.); (M.E.); (M.I.); (M.S.)
| | - Toshihiro Murata
- Department of Pharmacognosy, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai 981-8558, Japan;
| | - Adrian Zaragoza-Bastida
- Área Académica de Medicina Veterinaria y Zootecnia, Instituto de Ciencias Agropecuarias, Universidad Autónoma del Estado de Hidalgo, Rancho Universitario Av. Universidad km 1, EX-Hda de Aquetzalpa, Tulancingo, Hidalgo 43600, Mexico; (A.Z.-B.); (N.R.-P.)
| | - Nallely Rivero-Perez
- Área Académica de Medicina Veterinaria y Zootecnia, Instituto de Ciencias Agropecuarias, Universidad Autónoma del Estado de Hidalgo, Rancho Universitario Av. Universidad km 1, EX-Hda de Aquetzalpa, Tulancingo, Hidalgo 43600, Mexico; (A.Z.-B.); (N.R.-P.)
| | - Amany Magdy Beshbishy
- National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2-13, Inada-cho, Obihiro 080-8555, Hokkaido, Japan
- Correspondence: (G.E.-S.B.); (A.M.B.); (H.F.H.)
| | - Keneth Iceland Kasozi
- Infection Medicine, Deanery of Biomedical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ, UK;
| | - Philippe Jeandet
- Research Unit “Induced Resistance and Plant Bioprotection”, EA 4707, SFR Condorcet FR CNRS 3417, Faculty of Sciences, University of Reims, PO Box 1039, CEDEX 2, 51687 Reims, France;
| | - Helal F. Hetta
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt
- Department of Internal Medicine, University of Cincinnati College of Medicine, Clifton Ave, Cincinnati, OH 45221, USA
- Correspondence: (G.E.-S.B.); (A.M.B.); (H.F.H.)
| |
Collapse
|
41
|
Affiliation(s)
- Zhanxue Gong
- Institute for Innovation & Entrepreneurship, South-Central University for Nationalities, Wuhan, China
| | - Xiyuan Li
- Economics and Management School, Wuhan University, Wuhan, China
| | - Mahmoud Ismail
- Faculty of Computers and Informatics, Zagazig University, Alsharqiya, Egypt
| |
Collapse
|
42
|
Lin YB, Fu JH, Huang Y, Hu YH, Luo KJ, Wang KX, Bella AÉ, Situ DR, Chen JY, Lin T, D’Journo XB, Novoa NM, Brunelli A, Fernando HC, Cerfolio RJ, Ismail M, Yang H. Fibrin sealant for esophageal anastomosis: A phase II study. World J Gastrointest Oncol 2020; 12:651-662. [PMID: 32699580 PMCID: PMC7340992 DOI: 10.4251/wjgo.v12.i6.651] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Revised: 03/28/2020] [Accepted: 05/05/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Esophagectomy is a pivotal curative modality for localized esophageal or esophagogastric junction cancer (EC or EJC). Postoperative anastomotic leakage (AL) remains problematic. The use of fibrin sealant (FS) may improve the strength of esophageal anastomosis and reduce the incidence of AL.
AIM To assess the efficacy and safety of applying FS to prevent AL in patients with EC or EJC.
METHODS In this single-arm, phase II trial (Clinicaltrial.gov identifier: NCT03529266), we recruited patients aged 18-80 years with resectable EC or EJC clinically staged as T1-4aN0-3M0. An open or minimally invasive McKeown esophagectomy was performed with a circular stapled anastomosis. After performing the anastomosis, 2.5 mL of porcine FS was applied circumferentially. The primary endpoint was the proportion of patients with AL within 3 mo.
RESULTS From June 4, 2018, to December 29, 2018, 57 patients were enrolled. At the data cutoff date (June 30, 2019), three (5.3%) of the 57 patients had developed AL, including two (3.5%) with esophagogastric AL and one (1.8%) with gastric fistula. The incidence of anastomotic stricture and other major postoperative complications was 1.8% and 17.5%, respectively. The median time needed to resume oral feeding after operation was 8 d (Interquartile range: 7.0-9.0 d). No adverse events related to FS were recorded. No deaths occurred within 90 d after surgery.
CONCLUSION Perioperative sealing with porcine FS appears safe and may prevent AL after esophagectomy in patients with resectable EC or EJC. Further phase III studies are warranted.
Collapse
Affiliation(s)
- Yao-Bin Lin
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Jian-Hua Fu
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Yan Huang
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Yi-Huai Hu
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Kong-Jia Luo
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Ke-Xi Wang
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Amos Éla Bella
- Department of Thoracic Surgery, Avicenne Hospital, Bobigny 93000, France
- Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
| | - Dong-Rong Situ
- Department of Surgery, Royal Darwin Hospital, Northern Territory 0811, Australia
| | - Ji-Yang Chen
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Ting Lin
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | - Xavier B D’Journo
- Department of Thoracic Surgery and Diseases of Esophagus, Aix-Marseille University, Hôpital Nord, Marseille 13915, France
| | - Nuria M Novoa
- Thoracic Surgery Service, University Hospital of Salamanca, Salamanca 37007, Spain
| | - Alessandro Brunelli
- Department of Thoracic Surgery, St James's University Hospital, Leeds LS9 7TF, United Kingdom
| | - Hiran C Fernando
- Section of Thoracic Surgery, Inova Fairfax Medical Center, Inova Schar Cancer Institute, Falls Church, VA 22042, United States
| | - Robert J Cerfolio
- Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY 10016, United States
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Academic Hospital of the Charité–Universitätsmedizin, Humboldt University Berlin, Berlin 10117, Germany
| | - Hong Yang
- Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
| | | |
Collapse
|
43
|
Charlesworth JD, Baker FC, Kolotovska V, Adlou B, de Zambotti M, Ismail M, Raghunathan S, Singh H, Buchfuhrer MJ. 0794 Reduction in Restless Legs Syndrome Symptoms with Non-Invasive Peripheral Nerve Stimulation. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Restless Legs Syndrome (RLS) is a sensorimotor neurological condition characterized by an uncontrollable urge to move the legs that interferes with falling and staying asleep. For the over 5 million Americans with clinically significant RLS, these symptoms occur multiple nights per week, significantly impair quality of life, increase the prevalence of depression and anxiety, and increase suicide risk. FDA-approved medications for RLS are associated with progressively worsening RLS symptoms and numerous adverse events, whereas existing medical device treatments have limited efficacy.
Methods
We evaluated a novel neurostimulation intervention for RLS developed by Noctrix Health; electrical stimulation was applied non-invasively and bilaterally to the peroneal nerve of patients with moderate-to-severe primary RLS. Stimulation parameters were engineered to maximize therapeutic efficacy while minimizing interference with sleep. To assess the therapeutic efficacy of this technique, we conducted a multi-site randomized patient-blinded crossover trial comparing active neurostimulation treatment to a sham device. Following a lab visit for calibration, optimization, and training, each patient was instructed to self-administer each treatment - active and sham - for 14 consecutive nights at home.
Results
Active neurostimulation treatment resulted in a clinically significant reduction in RLS severity of 4.2 points on the International RLS Rating Scale (IRLS) relative to sham (P<0.01), comparable to FDA-approved medications. Moreover, 79% of patients demonstrated a clinically significant improvement on the Clinical Global Impressions-Improvement scale (CGI-I) compared to 7% for sham (P<0.01).
Conclusion
To our knowledge, this is the first sham-controlled study demonstrating a clinically significant reduction in RLS severity resulting from a non-pharmacological intervention. This therapeutic effect was sustained over 2-weeks of in-home patient-administered usage, indicating consistent efficacy. A medical device based on this technology could be a promising alternative or complement to medications.
Support
Funding was provided by Noctrix Health, Inc.
Collapse
Affiliation(s)
| | - F C Baker
- SRI International Human Sleep Research Lab, Menlo Park, CA
| | - V Kolotovska
- Sleep Medicine Specialists of California, San Ramon, CA
| | - B Adlou
- Noctrix Health, Inc., San Francisco, CA
| | - M de Zambotti
- SRI International Human Sleep Research Lab, Menlo Park, CA
| | - M Ismail
- SRI International Human Sleep Research Lab, Menlo Park, CA
| | | | - H Singh
- Sleep Medicine Specialists of California, San Ramon, CA
| | | |
Collapse
|
44
|
Abu Akar F, Gonzalez-Rivas D, Shaqqura B, Salman W, Ismail M, Safadi T, Adwan R, Al-Hassan H, Rumman N, Hijjeh N. Uniportal video assisted thoracoscopy versus open surgery for pulmonary hydatid disease-a single center experience. J Thorac Dis 2020; 12:794-802. [PMID: 32274146 PMCID: PMC7139009 DOI: 10.21037/jtd.2019.12.73] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Background Although rare in the Western world, the incidence of hydatid disease is still prevalent and strikingly endemic among the Palestinians. Until 2017, surgical treatment of lung pathologies was performed through the traditional incision (open thoracotomy). Uniportal video-assisted thoracoscopic surgery (VATS) approach has recently been applied in the cases of the pulmonary hydatid cysts with very satisfactory results. Methods Between January 2010 and January 2019, 39 patients with pulmonary HC disease have been surgically treated. The cases divided into two cohorts: operations performed by thoracotomy classified as group A, (n=16). Operations performed by uniportal VATS classified as group B, (n=23). Prospectively collected data was analysed retrospectively, and the results compared between both groups. Results No significant statistical differences were noticed in terms of demographics and comorbidity. Laboratory tests were similar except haemoglobin level, which was higher in group A (P=0.001). Despite that, blood transfusion was higher in group A (P=0.016). Moreover, operation time was longer in group A (P=0.000). Chest drainage remained longer in group A (P=0.077). The level of postoperative pain was significantly higher in group A certainly in POD 1 (P=0.000). Patients in group B discharged earlier from the hospital (P=0.011) and experienced lower complications (P=0.060). No significant difference in length of ICU stay. Neither recurrence nor 30-day mortality recorded in either group. Conclusions Uniportal VATS can be safely applied for pulmonary hydatidosis. It also seems to have a preference in several aspects compared to open Thoracotomy approach.
Collapse
Affiliation(s)
- Firas Abu Akar
- Department of Cardiothoracic Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Diego Gonzalez-Rivas
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.,Department of Thoracic Surgery, Coruña University Hospital, Coruña, Spain
| | - Bisanne Shaqqura
- Department of Cardiothoracic Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Waseem Salman
- Department of Cardiothoracic Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Academic Hospital of the Charité - Universitätsmedizin Humboldt University Berlin, Berlin, Germany
| | - Tammah Safadi
- Department of Cardiothoracic Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Rabee Adwan
- Infectious Diseases Unit, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Haitham Al-Hassan
- Division of Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Nisreen Rumman
- Department of Pediatrics, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| | - Nizar Hijjeh
- Department of Cardiothoracic Surgery, Makassed Charitable Society Hospital, East Jerusalem, Palestine
| |
Collapse
|
45
|
Alhmoud T, Gremida A, Colom Steele D, Fallahi I, Tuqan W, Nandy N, Ismail M, Aburajab Altamimi B, Xiong MJ, Kerwin A, Martin D. Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation. BMJ Open Gastroenterol 2020; 7:e000373. [PMID: 32128230 PMCID: PMC7039632 DOI: 10.1136/bmjgast-2020-000373] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Revised: 01/22/2020] [Accepted: 01/27/2020] [Indexed: 12/28/2022] Open
Abstract
Background Inflammatory bowel disease (IBD) is characterised by acute intestinal mucosal inflammation with chronic inflammatory features. Various degrees of mucosal eosinophilia are present along with the typical acute (neutrophil-predominant) inflammation. The effect of intestinal eosinophils on IBD outcomes remains unclear. Methods This is a retrospective study. Archived intestinal mucosal biopsy specimens of treatment-naïve IBD patients were examined by two pathologists. The number of eosinophils per high-power field was counted, and the mucosal inflammation was classified according to the eosinophilic inflammatory patterns. Clinical outcomes during the follow-up period were recorded. Results 142 treatment-naïve IBD patients were included. Mean age was 39 years. 83% of patients had ulcerative colitis, and median follow-up was 3 years. 41% of patients had disease flare(s) and 24% required hospitalisation. Eosinophil count was not associated with risk of disease flare or hospitalisation. Patients with neutrophil-predominant inflammation (>70% neutrophils) had greater risk of disease flare(s): 27(55%) versus 24(36%) and 7(28%) in patients with mixed and eosinophil-predominant inflammation, respectively (p=0.04). Overall, patients with neutrophil-predominant inflammation were more likely to have a disease flare; HR: 2.49, 95% CI (1.0 to 5.6). Hospitalisation rate was higher in patients with neutrophil-predominant inflammation: 17(35%) compared to 17(19%) in patients with eosinophil-rich inflammation (p=0.04). Kaplan-Meier analysis showed higher flare-free survival in patients with eosinophil-predominant inflammation compared to mixed and neutrophil-predominant inflammation. Conclusion IBD patients with eosinophil-predominant inflammation phenotype might have reduced risk of disease flares and hospitalisation. Larger prospective studies to assess IBD outcomes in this subpopulation are warranted.
Collapse
Affiliation(s)
- Tarik Alhmoud
- Division of Gastroenterology and Hepatology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Anas Gremida
- Division of Gastroenterology and Hepatology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Diego Colom Steele
- Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Imaneh Fallahi
- Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Wael Tuqan
- Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Nina Nandy
- Division of Gastroenterology and Hepatology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Mahmoud Ismail
- Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Barakat Aburajab Altamimi
- Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Meng-Jun Xiong
- Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - Audra Kerwin
- Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| | - David Martin
- Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA
| |
Collapse
|
46
|
Jang M, Costa C, Bunch J, Gibson B, Ismail M, Palitsin V, Webb R, Hudson M, Bailey MJ. On the relevance of cocaine detection in a fingerprint. Sci Rep 2020; 10:1974. [PMID: 32029797 PMCID: PMC7005170 DOI: 10.1038/s41598-020-58856-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2019] [Accepted: 12/17/2019] [Indexed: 12/13/2022] Open
Abstract
The finding that drugs and metabolites can be detected from fingerprints is of potential relevance to forensic science and as well as toxicology and clinical testing. However, discriminating between dermal contact and ingestion of drugs has never been verified experimentally. The inability to interpret the result of finding a drug or metabolite in a fingerprint has prevented widespread adoption of fingerprints in drug testing and limits the probative value of detecting drugs in fingermarks. A commonly held belief is that the detection of metabolites of drugs of abuse in fingerprints can be used to confirm a drug has been ingested. However, we show here that cocaine and its primary metabolite, benzoylecgonine, can be detected in fingerprints of non-drug users after contact with cocaine. Additionally, cocaine was found to persist above environmental levels for up to 48 hours after contact. Therefore the detection of cocaine and benzoylecgonine (BZE) in fingermarks can be forensically significant, but do not demonstrate that a person has ingested the substance. In contrast, the data here shows that a drug test from a fingerprint (where hands can be washed prior to donating a sample) CAN distinguish between contact and ingestion of cocaine. If hands were washed prior to giving a fingerprint, BZE was detected only after the administration of cocaine. Therefore BZE can be used to distinguish cocaine contact from cocaine ingestion, provided donors wash their hands prior to sampling. A test based on the detection of BZE in at least one of two donated fingerprint samples has accuracy 95%, sensitivity 90% and specificity of 100% (n = 86).
Collapse
Affiliation(s)
- M Jang
- Department of Chemistry, University of Surrey, Guildford, GU2 7XH, UK
| | - C Costa
- Ion Beam Centre, University of Surrey, Guildford, GU2 7XH, UK
| | - J Bunch
- National Physical Laboratory, Teddington, TW11 0LW, UK
| | - B Gibson
- Forensic Science Ireland, Dublin, Republic of Ireland
| | - M Ismail
- Department of Chemistry, University of Surrey, Guildford, GU2 7XH, UK
| | - V Palitsin
- Ion Beam Centre, University of Surrey, Guildford, GU2 7XH, UK
| | - R Webb
- Ion Beam Centre, University of Surrey, Guildford, GU2 7XH, UK
| | - M Hudson
- Intelligent Fingerprinting Limited, Milton Road, Impington, Cambridge, CB24 9NG, UK
| | - M J Bailey
- Department of Chemistry, University of Surrey, Guildford, GU2 7XH, UK.
| |
Collapse
|
47
|
AlMulla A, Hassan-Yassoub N, Fu D, El-Awa F, Alebshehy R, Ismail M, Fraser CP. Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019. East Mediterr Health J 2020; 26:110-115. [PMID: 32043553 DOI: 10.26719/2020.26.1.110] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 12/15/2019] [Indexed: 11/09/2022]
Abstract
The report aimed to review and assess the status of tobacco cessation services in the Eastern Mediterranean Region (EMR). Nearly 70% of people in the Region have legal access to nicotine-replacement therapy but for 77% of these people the costs of the treatment are not covered. Bupropion and Varenicline are legally available in 10 and 11 EMR countries respectively. Just under 50% of people in the Region have access to at least some cessation support in primary health care facilities. Around 32% of people have access to a national toll-free quit line. Costs for cessation services are fully covered in few EMR countries; however, cessation services in the Region must be improved. Member States should aim to increase the availability of, and financial support for, cessation treatments and support, which should be prioritized in primary health care facilities.
Collapse
Affiliation(s)
- Ahmad AlMulla
- Tobacco Control Center, WHO Collaborative Center, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
| | - Norr Hassan-Yassoub
- Tobacco Control Center, WHO Collaborative Center, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
| | - Dongbo Fu
- Tobacco Free Initiative, Prevention of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland
| | - Fatimah El-Awa
- Tobacco Free Initiative, Department Noncommunicable Diseases and Mental Health, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt
| | | | - Mahmoud Ismail
- Tobacco Free Initiative, Department Noncommunicable Diseases and Mental Health, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt
| | - Charles P Fraser
- Tobacco Free Initiative, Department Noncommunicable Diseases and Mental Health, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt
| |
Collapse
|
48
|
Ismail M, Wakiel H, Ghany DA, Shakweer M, Lotfy A, Gaballah A. Correlation between tumour infiltration lymphocyte and PDL-1 expression in laryngeal cancer and its prognostic significance: A prospective, non-interventional trial. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz452.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Li F, Li Z, Takahashi R, Ioannis A, Ismail M, Meisel A, Rueckert JC. Robotic-Extended Rethymectomy for Refractory Myasthenia Gravis: A Case Series. Semin Thorac Cardiovasc Surg 2019; 32:593-602. [PMID: 31682904 DOI: 10.1053/j.semtcvs.2019.10.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2019] [Accepted: 10/25/2019] [Indexed: 11/11/2022]
Abstract
To assess the safety and efficacy of robotic-extended rethymectomy in selected refractory myasthenia gravis (MG) patients with suspected residual thymic tissue. Robotic-extended rethymectomy was performed in 6 MG patients with seropositive acetylcholine receptors (AChR) antibody who had undergone a previous thymectomy (1 cervicotomy, 2 video-assisted thoracoscopic surgeries, and 3 sternotomies). The median observation time before robotic rethymectomy was 108 (24-171) months. The main outcomes were perioperative morbidity, mortality, conversion to open surgery, and clinical outcomes according to the Myasthenia Gravis Foundation of America Post-Intervention Status (MGFA-PIS). Before rethymectomy, all patients required immunosuppressants and 5 patients (83.3%) required intravenous immune globulin and/or plasma exchange to control the symptoms. The median specimen weight was 24.5 (14-144) g after rethymectomy, and residual thymic tissue was found in 5 patients (83.3%). No conversion to open surgery or perioperative morbidity and mortality was observed. With a median follow-up time of 46.5 (13-155) months, 3 patients (50%) achieved "improved" and 3 (50%) were "unchanged" according to the MGFA-PIS. Compared with preoperative use, the median daily dose of corticosteroids statistically decreased (25 [7.5-60] vs 0 [0-5] mg, P = 0.002) without significant change in azathioprine use (100 [0-200] vs 50 [0-150] mg, P = 0.360). AChR antibody positive MG patients with a treatment refractory long-term course after thymectomy might have remaining thymic tissue with the 2 commonly associated thymus pathologies, thymoma, and follicular hyperplasia. Robotic-extended rethymectomy might be considered as a safe and beneficial treatment option in these patients.
Collapse
Affiliation(s)
- Feng Li
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Zhongmin Li
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Reona Takahashi
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | | | - Mahmoud Ismail
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany
| | - Andreas Meisel
- Department of Neurology Berlin, Charité University Hospital Berlin, Berlin, Germany
| | - Jens-C Rueckert
- Department of Surgery, Competence Center of Thoracic Surgery, Charité University Hospital Berlin, Berlin, Germany.
| |
Collapse
|
50
|
Ismail M, Nachira D. Devising the guidelines: the concept of uniportal video-assisted thoracic surgery-instrumentation and operatory room staff. J Thorac Dis 2019; 11:S2079-S2085. [PMID: 31637042 DOI: 10.21037/jtd.2019.08.69] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
In the last years, uniportal video-assisted thoracic surgery (VATS) has been gaining more and more popularity, becoming a common procedure in several thoracic centers all over the world not only for minor procedures but also for major and complex cases. This technique combines the advantages of the less invasiveness with the oncological principles of open surgery. A standardization of the different peri- and intraoperative steps can help in the establishment and development of this technique. The aim of this paper is to set the basic steps for operating room set-up and instrumentation for starting or improving a uniportal VATS program in thoracic surgery centers.
Collapse
Affiliation(s)
- Mahmoud Ismail
- Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany
| | - Dania Nachira
- Department of Thoracic Surgery, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|